{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T14:35:49Z","timestamp":1792852549551,"version":"4.5.0"},"reference-count":300,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2025,3,11]],"date-time":"2025-03-11T00:00:00Z","timestamp":1741651200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,3,11]],"date-time":"2025-03-11T00:00:00Z","timestamp":1741651200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Pharmacol Sin"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1038\/s41401-025-01499-6","type":"journal-article","created":{"date-parts":[[2025,3,11]],"date-time":"2025-03-11T04:00:05Z","timestamp":1741665605000},"page":"2075-2092","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Epigenetic regulation of iron metabolism and ferroptosis in Parkinson\u2019s disease: Identifying novel epigenetic targets"],"prefix":"10.1038","volume":"46","author":[{"given":"Xiao-die","family":"Gao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-e","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun-xia","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua-min","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,11]]},"reference":[{"key":"1499_CR1","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1176\/jnp.14.2.223","volume":"14","author":"J Parkinson","year":"2002","unstructured":"Parkinson J. An essay on the shaking palsy. J Neuropsychiatry Clin Neurosci. 2002;14:223\u201336. https:\/\/doi.org\/10.1176\/jnp.14.2.223.","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"1499_CR2","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.freeradbiomed.2013.01.018","volume":"62","author":"DT Dexter","year":"2013","unstructured":"Dexter DT, Jenner P. Parkinson disease: from pathology to molecular disease mechanisms. Free Radic Biol Med. 2013;62:132\u201344. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2013.01.018.","journal-title":"Free Radic Biol Med"},{"key":"1499_CR3","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/s41531-018-0058-0","volume":"4","author":"C Marras","year":"2018","unstructured":"Marras C, Beck JC, Bower JH, Roberts E, Ritz B, Ross GW, et al. Prevalence of Parkinson\u2019s disease across North America. NPJ Park Dis. 2018;4:21 https:\/\/doi.org\/10.1038\/s41531-018-0058-0.","journal-title":"NPJ Park Dis"},{"key":"1499_CR4","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/s0140-6736(23)01419-8","volume":"403","author":"Y Ben-Shlomo","year":"2024","unstructured":"Ben-Shlomo Y, Darweesh S, Llibre-Guerra J, Marras C, San Luciano M, Tanner C. The epidemiology of Parkinson\u2019s disease. Lancet. 2024;403:283\u201392. https:\/\/doi.org\/10.1016\/s0140-6736(23)01419-8.","journal-title":"Lancet"},{"key":"1499_CR5","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/s1474-4422(18)30499-x","volume":"18","author":"GN Collaborators","year":"2019","unstructured":"Collaborators GN. Global, regional, and national burden of neurological disorders, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2019;18:459\u201380. https:\/\/doi.org\/10.1016\/s1474-4422(18)30499-x.","journal-title":"Lancet Neurol"},{"key":"1499_CR6","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.3233\/jpd-181474","volume":"8","author":"ER Dorsey","year":"2018","unstructured":"Dorsey ER, Sherer T, Okun MS, Bloem BR. The emerging evidence of the Parkinson pandemic. J Park Dis. 2018;8:S3\u2013s8. https:\/\/doi.org\/10.3233\/jpd-181474.","journal-title":"J Park Dis"},{"key":"1499_CR7","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.tins.2024.01.002","volume":"47","author":"J Wang","year":"2024","unstructured":"Wang J, Dai L, Chen S, Zhang Z, Fang X, Zhang Z. Protein-protein interactions regulating \u03b1-synuclein pathology. Trends Neurosci 2024;47:209\u201326. https:\/\/doi.org\/10.1016\/j.tins.2024.01.002.","journal-title":"Trends Neurosci"},{"key":"1499_CR8","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/s1353-8020(09)70769-2","volume":"15","author":"DW Dickson","year":"2009","unstructured":"Dickson DW, Fujishiro H, Orr C, DelleDonne A, Josephs KA, Frigerio R, et al. Neuropathology of non-motor features of Parkinson disease. Park Relat Disord. 2009;15:S1\u20135. https:\/\/doi.org\/10.1016\/s1353-8020(09)70769-2.","journal-title":"Park Relat Disord"},{"key":"1499_CR9","doi-asserted-by":"publisher","first-page":"132","DOI":"10.31083\/j.jin2205132","volume":"22","author":"C Cattaneo","year":"2023","unstructured":"Cattaneo C, Jost WH. Pain in Parkinson\u2019s disease: pathophysiology, classification and treatment. J Integr Neurosci. 2023;22:132. https:\/\/doi.org\/10.31083\/j.jin2205132.","journal-title":"J Integr Neurosci"},{"key":"1499_CR10","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1001\/jamaneurol.2023.3382","volume":"80","author":"A Terracciano","year":"2023","unstructured":"Terracciano A, Luchetti M, Karakose S, Stephan Y, Sutin AR. Loneliness and risk of Parkinson disease. JAMA Neurol. 2023;80:1138\u201344. https:\/\/doi.org\/10.1001\/jamaneurol.2023.3382.","journal-title":"JAMA Neurol"},{"key":"1499_CR11","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2020.620762","volume":"12","author":"R Ou","year":"2020","unstructured":"Ou R, Lin J, Liu K, Jiang Z, Wei Q, Hou Y, et al. Evolution of apathy in early Parkinson\u2019s disease: A 4-years prospective cohort study. Front Aging Neurosci. 2020;12:620762. https:\/\/doi.org\/10.3389\/fnagi.2020.620762.","journal-title":"Front Aging Neurosci"},{"key":"1499_CR12","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1002\/mds.26643","volume":"31","author":"MP Broen","year":"2016","unstructured":"Broen MP, Narayen NE, Kuijf ML, Dissanayaka NN, Leentjens AF. Prevalence of anxiety in Parkinson\u2019s disease: a systematic review and meta-analysis. Mov Disord. 2016;31:1125\u201333. https:\/\/doi.org\/10.1002\/mds.26643.","journal-title":"Mov Disord"},{"key":"1499_CR13","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.cger.2020.01.001","volume":"36","author":"JG Goldman","year":"2020","unstructured":"Goldman JG, Sieg E. Cognitive impairment and dementia in Parkinson disease. Clin Geriatr Med. 2020;36:365\u201377. https:\/\/doi.org\/10.1016\/j.cger.2020.01.001.","journal-title":"Clin Geriatr Med"},{"key":"1499_CR14","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1001\/jama.2019.22360","volume":"323","author":"MJ Armstrong","year":"2020","unstructured":"Armstrong MJ, Okun MS. Diagnosis and treatment of Parkinson disease: a review. JAMA. 2020;323:548\u201360. https:\/\/doi.org\/10.1001\/jama.2019.22360.","journal-title":"JAMA"},{"key":"1499_CR15","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/s1474-4422(06)70471-9","volume":"5","author":"LM de Lau","year":"2006","unstructured":"de Lau LM, Breteler MM. Epidemiology of Parkinson\u2019s disease. Lancet Neurol. 2006;5:525\u201335. https:\/\/doi.org\/10.1016\/s1474-4422(06)70471-9.","journal-title":"Lancet Neurol"},{"key":"1499_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.parkreldis.2015.12.008","volume":"23","author":"V Bellou","year":"2016","unstructured":"Bellou V, Belbasis L, Tzoulaki I, Evangelou E, Ioannidis JP. Environmental risk factors and Parkinson\u2019s disease: An umbrella review of meta-analyses. Park Relat Disord. 2016;23:1\u20139. https:\/\/doi.org\/10.1016\/j.parkreldis.2015.12.008.","journal-title":"Park Relat Disord"},{"key":"1499_CR17","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/s0140-6736(23)01478-2","volume":"403","author":"HR Morris","year":"2024","unstructured":"Morris HR, Spillantini MG, Sue CM, Williams-Gray CH. The pathogenesis of Parkinson\u2019s disease. Lancet. 2024;403:293\u2013304. https:\/\/doi.org\/10.1016\/s0140-6736(23)01478-2.","journal-title":"Lancet"},{"key":"1499_CR18","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/s41392-023-01353-3","volume":"8","author":"X Dong-Chen","year":"2023","unstructured":"Dong-Chen X, Yong C, Yang X, Chen-Yu S, Li-Hua P. Signaling pathways in Parkinson\u2019s disease: molecular mechanisms and therapeutic interventions. Signal Transduct Target Ther. 2023;8:73. https:\/\/doi.org\/10.1038\/s41392-023-01353-3.","journal-title":"Signal Transduct Target Ther"},{"key":"1499_CR19","doi-asserted-by":"publisher","first-page":"3321","DOI":"10.1016\/j.neurobiolaging.2015.08.024","volume":"36","author":"HJ Jyothi","year":"2015","unstructured":"Jyothi HJ, Vidyadhara DJ, Mahadevan A, Philip M, Parmar SK, Manohari SG, et al. Aging causes morphological alterations in astrocytes and microglia in human substantia nigra pars compacta. Neurobiol Aging. 2015;36:3321\u201333. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2015.08.024.","journal-title":"Neurobiol Aging"},{"key":"1499_CR20","doi-asserted-by":"publisher","first-page":"501","DOI":"10.3233\/jpd-191683","volume":"9","author":"S Cerri","year":"2019","unstructured":"Cerri S, Mus L, Blandini F. Parkinson\u2019s disease in women and men: what\u2019s the difference?. J Park Dis. 2019;9:501\u201315. https:\/\/doi.org\/10.3233\/jpd-191683.","journal-title":"J Park Dis"},{"key":"1499_CR21","doi-asserted-by":"publisher","first-page":"e464","DOI":"10.1016\/s2666-7568(24)00094-1","volume":"5","author":"J Zhu","year":"2024","unstructured":"Zhu J, Cui Y, Zhang J, Yan R, Su D, Zhao D, et al. Temporal trends in the prevalence of Parkinson\u2019s disease from 1980 to 2023: a systematic review and meta-analysis. Lancet Healthy Longev. 2024;5:e464\u2013e479. https:\/\/doi.org\/10.1016\/s2666-7568(24)00094-1.","journal-title":"Lancet Healthy Longev"},{"key":"1499_CR22","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1002\/mds.27720","volume":"34","author":"C Marras","year":"2019","unstructured":"Marras C, Canning CG, Goldman SM. Environment, lifestyle, and Parkinson\u2019s disease: Implications for prevention in the next decade. Mov Disord. 2019;34:801\u201311. https:\/\/doi.org\/10.1002\/mds.27720.","journal-title":"Mov Disord"},{"key":"1499_CR23","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.cca.2022.02.006","volume":"529","author":"R Chen","year":"2022","unstructured":"Chen R, Gu X, Wang X. \u03b1-Synuclein in Parkinson\u2019s disease and advances in detection. Clin Chim Acta. 2022;529:76\u201386. https:\/\/doi.org\/10.1016\/j.cca.2022.02.006.","journal-title":"Clin Chim Acta"},{"key":"1499_CR24","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/s1474-4422(23)00109-6","volume":"22","author":"A Siderowf","year":"2023","unstructured":"Siderowf A, Concha-Marambio L, Lafontant DE, Farris CM, Ma Y, Urenia PA, et al. Assessment of heterogeneity among participants in the Parkinson\u2019s Progression Markers Initiative cohort using \u03b1-synuclein seed amplification: a cross-sectional study. Lancet Neurol. 2023;22:407\u201317. https:\/\/doi.org\/10.1016\/s1474-4422(23)00109-6.","journal-title":"Lancet Neurol"},{"key":"1499_CR25","doi-asserted-by":"publisher","unstructured":"Marogianni C, Sokratous M, Dardiotis E, Hadjigeorgiou GM, Bogdanos D, Xiromerisiou G. Neurodegeneration and Inflammation-An Interesting Interplay in Parkinson\u2019s disease. Int J Mol Sci. 2020; 21:https:\/\/doi.org\/10.3390\/ijms21228421.","DOI":"10.3390\/ijms21228421"},{"key":"1499_CR26","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.tibs.2020.11.007","volume":"46","author":"AB Malpartida","year":"2021","unstructured":"Malpartida AB, Williamson M, Narendra DP, Wade-Martins R, Ryan BJ. Mitochondrial dysfunction and mitophagy in Parkinson\u2019s disease: from mechanism to therapy. Trends Biochem Sci. 2021;46:329\u201343. https:\/\/doi.org\/10.1016\/j.tibs.2020.11.007.","journal-title":"Trends Biochem Sci"},{"key":"1499_CR27","doi-asserted-by":"publisher","DOI":"10.1186\/s40168-021-01107-9","volume":"9","author":"Z Zhao","year":"2021","unstructured":"Zhao Z, Ning J, Bao XQ, Shang M, Ma J, Li G, et al. Fecal microbiota transplantation protects rotenone-induced Parkinson\u2019s disease mice via suppressing inflammation mediated by the lipopolysaccharide-TLR4 signaling pathway through the microbiota-gut-brain axis. Microbiome. 2021;9:226. https:\/\/doi.org\/10.1186\/s40168-021-01107-9.","journal-title":"Microbiome"},{"key":"1499_CR28","doi-asserted-by":"publisher","DOI":"10.1111\/acel.13031","volume":"18","author":"BG Trist","year":"2019","unstructured":"Trist BG, Hare DJ, Double KL. Oxidative stress in the aging substantia nigra and the etiology of Parkinson\u2019s disease. Aging Cell. 2019;18:e13031. https:\/\/doi.org\/10.1111\/acel.13031.","journal-title":"Aging Cell"},{"key":"1499_CR29","doi-asserted-by":"publisher","first-page":"3114","DOI":"10.1093\/brain\/awab191","volume":"144","author":"E Biondetti","year":"2021","unstructured":"Biondetti E, Santin MD, Valabr\u00e8gue R, Mangone G, Gaurav R, Pyatigorskaya N, et al. The spatiotemporal changes in dopamine, neuromelanin and iron characterizing Parkinson\u2019s disease. Brain. 2021;144:3114\u201325. https:\/\/doi.org\/10.1093\/brain\/awab191.","journal-title":"Brain"},{"key":"1499_CR30","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.1007\/s11064-021-03334-w","volume":"46","author":"AS Rathore","year":"2021","unstructured":"Rathore AS, Birla H, Singh SS, Zahra W, Dilnashin H, Singh R, et al. Epigenetic modulation in Parkinson\u2019s disease and potential treatment therapies. Neurochem Res. 2021;46:1618\u201326. https:\/\/doi.org\/10.1007\/s11064-021-03334-w.","journal-title":"Neurochem Res"},{"key":"1499_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2023.102077","volume":"91","author":"XS Ding","year":"2023","unstructured":"Ding XS, Gao L, Han Z, Eleuteri S, Shi W, Shen Y, et al. Ferroptosis in Parkinson\u2019s disease: Molecular mechanisms and therapeutic potential. Ageing Res Rev. 2023;91:102077. https:\/\/doi.org\/10.1016\/j.arr.2023.102077.","journal-title":"Ageing Res Rev"},{"key":"1499_CR32","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202300325","volume":"10","author":"Y Wang","year":"2023","unstructured":"Wang Y, Wu S, Li Q, Sun H, Wang H. Pharmacological inhibition of ferroptosis as a therapeutic target for neurodegenerative diseases and strokes. Adv Sci. 2023;10:e2300325. https:\/\/doi.org\/10.1002\/advs.202300325.","journal-title":"Adv Sci"},{"key":"1499_CR33","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.1002\/med.21962","volume":"43","author":"D Zhang","year":"2023","unstructured":"Zhang D, Zhang J, Wang Y, Wang G, Tang P, Liu Y, et al. Targeting epigenetic modifications in Parkinson\u2019s disease therapy. Med Res Rev. 2023;43:1748\u201377. https:\/\/doi.org\/10.1002\/med.21962.","journal-title":"Med Res Rev"},{"key":"1499_CR34","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2020.616083","volume":"11","author":"X Wei","year":"2020","unstructured":"Wei X, Cai M, Jin L. The function of the metals in regulating epigenetics during Parkinson\u2019s disease. Front Genet. 2020;11:616083. https:\/\/doi.org\/10.3389\/fgene.2020.616083.","journal-title":"Front Genet"},{"key":"1499_CR35","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1016\/s1474-4422(14)70117-6","volume":"13","author":"RJ Ward","year":"2014","unstructured":"Ward RJ, Zucca FA, Duyn JH, Crichton RR, Zecca L. The role of iron in brain ageing and neurodegenerative disorders. Lancet Neurol. 2014;13:1045\u201360. https:\/\/doi.org\/10.1016\/s1474-4422(14)70117-6.","journal-title":"Lancet Neurol"},{"key":"1499_CR36","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2220300120","volume":"120","author":"H Geng","year":"2023","unstructured":"Geng H, Li Z, Li Z, Zhang Y, Gao Z, Sun L, et al. Restoring neuronal iron homeostasis revitalizes neurogenesis after spinal cord injury. Proc Natl Acad Sci USA. 2023;120:e2220300120. https:\/\/doi.org\/10.1073\/pnas.2220300120.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1499_CR37","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/978-1-4939-2095-2_10","volume":"844","author":"J Chifman","year":"2014","unstructured":"Chifman J, Laubenbacher R, Torti SV. A systems biology approach to iron metabolism. Adv Exp Med Biol. 2014;844:201\u201325. https:\/\/doi.org\/10.1007\/978-1-4939-2095-2_10.","journal-title":"Adv Exp Med Biol"},{"key":"1499_CR38","doi-asserted-by":"publisher","first-page":"3078","DOI":"10.1007\/s12035-016-9879-1","volume":"54","author":"H Jiang","year":"2017","unstructured":"Jiang H, Wang J, Rogers J, Xie J. Brain Iron metabolism dysfunction in Parkinson\u2019s disease. Mol Neurobiol. 2017;54:3078\u2013101. https:\/\/doi.org\/10.1007\/s12035-016-9879-1.","journal-title":"Mol Neurobiol"},{"key":"1499_CR39","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1016\/j.bbadis.2018.01.008","volume":"1864","author":"N Song","year":"2018","unstructured":"Song N, Wang J, Jiang H, Xie J. Astroglial and microglial contributions to iron metabolism disturbance in Parkinson\u2019s disease. Biochim Biophys Acta Mol Basis Dis. 2018;1864:967\u201373. https:\/\/doi.org\/10.1016\/j.bbadis.2018.01.008.","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"1499_CR40","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.pneurobio.2015.09.012","volume":"155","author":"FA Zucca","year":"2017","unstructured":"Zucca FA, Segura-Aguilar J, Ferrari E, Mu\u00f1oz P, Paris I, Sulzer D, et al. Interactions of iron, dopamine and neuromelanin pathways in brain aging and Parkinson\u2019s disease. Prog Neurobiol. 2017;155:96\u2013119. https:\/\/doi.org\/10.1016\/j.pneurobio.2015.09.012.","journal-title":"Prog Neurobiol"},{"key":"1499_CR41","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1002\/mds.26218","volume":"30","author":"N Pyatigorskaya","year":"2015","unstructured":"Pyatigorskaya N, Sharman M, Corvol JC, Valabregue R, Yahia-Cherif L, Poupon F, et al. High nigral iron deposition in LRRK2 and Parkin mutation carriers using R2* relaxometry. Mov Disord. 2015;30:1077\u201384. https:\/\/doi.org\/10.1002\/mds.26218.","journal-title":"Mov Disord"},{"key":"1499_CR42","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1097\/WNR.0b013e328354a1f0","volume":"23","author":"F Febbraro","year":"2012","unstructured":"Febbraro F, Giorgi M, Caldarola S, Loreni F, Romero-Ramos M. \u03b1-Synuclein expression is modulated at the translational level by iron. Neuroreport. 2012;23:576\u201380. https:\/\/doi.org\/10.1097\/WNR.0b013e328354a1f0.","journal-title":"Neuroreport"},{"key":"1499_CR43","doi-asserted-by":"publisher","first-page":"6048","DOI":"10.1523\/jneurosci.20-16-06048.2000","volume":"20","author":"N Ostrerova-Golts","year":"2000","unstructured":"Ostrerova-Golts N, Petrucelli L, Hardy J, Lee JM, Farer M, Wolozin B. The A53T alpha-synuclein mutation increases iron-dependent aggregation and toxicity. J Neurosci. 2000;20:6048\u201354. https:\/\/doi.org\/10.1523\/jneurosci.20-16-06048.2000.","journal-title":"J Neurosci"},{"key":"1499_CR44","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1016\/j.neurobiolaging.2006.04.003","volume":"28","author":"D Kaur","year":"2007","unstructured":"Kaur D, Peng J, Chinta SJ, Rajagopalan S, Di Monte DA, Cherny RA, et al. Increased murine neonatal iron intake results in Parkinson-like neurodegeneration with age. Neurobiol Aging. 2007;28:907\u201313. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2006.04.003.","journal-title":"Neurobiol Aging"},{"key":"1499_CR45","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1111\/jnc.13425","volume":"139","author":"AA Belaidi","year":"2016","unstructured":"Belaidi AA, Bush AI. Iron neurochemistry in Alzheimer\u2019s disease and Parkinson\u2019s disease: targets for therapeutics. J Neurochem. 2016;139:179\u201397. https:\/\/doi.org\/10.1111\/jnc.13425.","journal-title":"J Neurochem"},{"key":"1499_CR46","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.expneurol.2016.03.016","volume":"280","author":"C Guo","year":"2016","unstructured":"Guo C, Hao LJ, Yang ZH, Chai R, Zhang S, Gu Y, et al. Deferoxamine-mediated up-regulation of HIF-1\u03b1 prevents dopaminergic neuronal death via the activation of MAPK family proteins in MPTP-treated mice. Exp Neurol. 2016;280:13\u201323. https:\/\/doi.org\/10.1016\/j.expneurol.2016.03.016.","journal-title":"Exp Neurol"},{"key":"1499_CR47","doi-asserted-by":"publisher","first-page":"3591","DOI":"10.1523\/jneurosci.3439-14.2015","volume":"35","author":"S Ayton","year":"2015","unstructured":"Ayton S, Lei P, Hare DJ, Duce JA, George JL, Adlard PA, et al. Parkinson\u2019s disease iron deposition caused by nitric oxide-induced loss of \u03b2-amyloid precursor protein. J Neurosci. 2015;35:3591\u20137. https:\/\/doi.org\/10.1523\/jneurosci.3439-14.2015.","journal-title":"J Neurosci"},{"key":"1499_CR48","doi-asserted-by":"publisher","DOI":"10.1186\/s12883-015-0331-3","volume":"15","author":"G Grolez","year":"2015","unstructured":"Grolez G, Moreau C, Sablonni\u00e8re B, Gar\u00e7on G, Devedjian JC, Meguig S, et al. Ceruloplasmin activity and iron chelation treatment of patients with Parkinson\u2019s disease. BMC Neurol. 2015;15:74. https:\/\/doi.org\/10.1186\/s12883-015-0331-3.","journal-title":"BMC Neurol"},{"key":"1499_CR49","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1056\/NEJMoa2209254","volume":"387","author":"D Devos","year":"2022","unstructured":"Devos D, Labreuche J, Rascol O, Corvol JC, Duhamel A, Guyon Delannoy P, et al. Trial of deferiprone in Parkinson\u2019s disease. N Engl J Med. 2022;387:2045\u201355. https:\/\/doi.org\/10.1056\/NEJMoa2209254.","journal-title":"N Engl J Med"},{"key":"1499_CR50","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1016\/j.freeradbiomed.2022.11.018","volume":"193","author":"N Zhang","year":"2022","unstructured":"Zhang N, Yu X, Song L, Xiao Z, Xie J, Xu H. Ferritin confers protection against iron-mediated neurotoxicity and ferroptosis through iron chelating mechanisms in MPP+-induced MES23.5 dopaminergic cells. Free Radic Biol Med. 2022;193:751\u201363. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2022.11.018.","journal-title":"Free Radic Biol Med"},{"key":"1499_CR51","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","volume":"149","author":"SJ Dixon","year":"2012","unstructured":"Dixon SJ, Lemberg KM, Lamprecht MR, Skouta R, Zaitsev EM, Gleason CE, et al. Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell. 2012;149:1060\u201372. https:\/\/doi.org\/10.1016\/j.cell.2012.03.042.","journal-title":"Cell"},{"key":"1499_CR52","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1038\/s41581-023-00689-x","volume":"19","author":"H Bay\u0131r","year":"2023","unstructured":"Bay\u0131r H, Dixon SJ, Tyurina YY, Kellum JA, Kagan VE. Ferroptotic mechanisms and therapeutic targeting of iron metabolism and lipid peroxidation in the kidney. Nat Rev Nephrol. 2023;19:315\u201336. https:\/\/doi.org\/10.1038\/s41581-023-00689-x.","journal-title":"Nat Rev Nephrol"},{"key":"1499_CR53","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.ccell.2024.03.011","volume":"42","author":"G Lei","year":"2024","unstructured":"Lei G, Zhuang L, Gan B. The roles of ferroptosis in cancer: Tumor suppression, tumor microenvironment, and therapeutic interventions. Cancer Cell. 2024;42:513\u201334. https:\/\/doi.org\/10.1016\/j.ccell.2024.03.011.","journal-title":"Cancer Cell"},{"key":"1499_CR54","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1038\/s41392-023-01606-1","volume":"8","author":"S Sun","year":"2023","unstructured":"Sun S, Shen J, Jiang J, Wang F, Min J. Targeting ferroptosis opens new avenues for the development of novel therapeutics. Signal Transduct Target Ther. 2023;8:372. https:\/\/doi.org\/10.1038\/s41392-023-01606-1.","journal-title":"Signal Transduct Target Ther"},{"key":"1499_CR55","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1038\/s41418-017-0012-4","volume":"25","author":"L Galluzzi","year":"2018","unstructured":"Galluzzi L, Vitale I, Aaronson SA, Abrams JM, Adam D, Agostinis P, et al. Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018. Cell Death Differ. 2018;25:486\u2013541. https:\/\/doi.org\/10.1038\/s41418-017-0012-4.","journal-title":"Cell Death Differ"},{"key":"1499_CR56","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/s41568-022-00459-0","volume":"22","author":"G Lei","year":"2022","unstructured":"Lei G, Zhuang L, Gan B. Targeting ferroptosis as a vulnerability in cancer. Nat Rev Cancer. 2022;22:381\u201396. https:\/\/doi.org\/10.1038\/s41568-022-00459-0.","journal-title":"Nat Rev Cancer"},{"key":"1499_CR57","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2021.105466","volume":"166","author":"N Li","year":"2021","unstructured":"Li N, Jiang W, Wang W, Xiong R, Wu X, Geng Q. Ferroptosis and its emerging roles in cardiovascular diseases. Pharmacol Res. 2021;166:105466. https:\/\/doi.org\/10.1016\/j.phrs.2021.105466.","journal-title":"Pharmacol Res"},{"key":"1499_CR58","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1016\/j.tem.2021.04.010","volume":"32","author":"A Ajoolabady","year":"2021","unstructured":"Ajoolabady A, Aslkhodapasandhokmabad H, Libby P, Tuomilehto J, Lip GYH, Penninger JM, et al. Ferritinophagy and ferroptosis in the management of metabolic diseases. Trends Endocrinol Metab. 2021;32:444\u201362. https:\/\/doi.org\/10.1016\/j.tem.2021.04.010.","journal-title":"Trends Endocrinol Metab"},{"key":"1499_CR59","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2022.102262","volume":"51","author":"Y Wang","year":"2022","unstructured":"Wang Y, Zhang M, Bi R, Su Y, Quan F, Lin Y, et al. ACSL4 deficiency confers protection against ferroptosis-mediated acute kidney injury. Redox Biol. 2022;51:102262. https:\/\/doi.org\/10.1016\/j.redox.2022.102262.","journal-title":"Redox Biol"},{"key":"1499_CR60","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.bbi.2021.01.003","volume":"93","author":"Y Cui","year":"2021","unstructured":"Cui Y, Zhang Y, Zhao X, Shao L, Liu G, Sun C, et al. ACSL4 exacerbates ischemic stroke by promoting ferroptosis-induced brain injury and neuroinflammation. Brain Behav Immun. 2021;93:312\u201321. https:\/\/doi.org\/10.1016\/j.bbi.2021.01.003.","journal-title":"Brain Behav Immun"},{"key":"1499_CR61","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.1038\/s41418-020-00685-9","volume":"28","author":"WD Bao","year":"2021","unstructured":"Bao WD, Pang P, Zhou XT, Hu F, Xiong W, Chen K, et al. Loss of ferroportin induces memory impairment by promoting ferroptosis in Alzheimer\u2019s disease. Cell Death Differ. 2021;28:1548\u201362. https:\/\/doi.org\/10.1038\/s41418-020-00685-9.","journal-title":"Cell Death Differ"},{"key":"1499_CR62","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/7769355","volume":"2022","author":"ZH Lin","year":"2022","unstructured":"Lin ZH, Liu Y, Xue NJ, Zheng R, Yan YQ, Wang ZX, et al. Quercetin protects against MPP(+)\/MPTP-induced dopaminergic neuron death in Parkinson\u2019s disease by inhibiting ferroptosis. Oxid Med Cell Longev. 2022;2022:7769355. https:\/\/doi.org\/10.1155\/2022\/7769355.","journal-title":"Oxid Med Cell Longev"},{"key":"1499_CR63","doi-asserted-by":"publisher","unstructured":"Chen X, Kang R, Kroemer G, Tang D. Ferroptosis in infection, inflammation, and immunity. J Exp Med. 2021; 218:https:\/\/doi.org\/10.1084\/jem.20210518.","DOI":"10.1084\/jem.20210518"},{"key":"1499_CR64","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.nbd.2016.05.011","volume":"94","author":"B Do Van","year":"2016","unstructured":"Do Van B, Gouel F, Jonneaux A, Timmerman K, Gel\u00e9 P, P\u00e9trault M, et al. Ferroptosis, a newly characterized form of cell death in Parkinson\u2019s disease that is regulated by PKC. Neurobiol Dis. 2016;94:169\u201378. https:\/\/doi.org\/10.1016\/j.nbd.2016.05.011.","journal-title":"Neurobiol Dis"},{"key":"1499_CR65","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.neuint.2017.01.004","volume":"104","author":"SJ Guiney","year":"2017","unstructured":"Guiney SJ, Adlard PA, Bush AI, Finkelstein DI, Ayton S. Ferroptosis and cell death mechanisms in Parkinson\u2019s disease. Neurochem Int. 2017;104:34\u201348. https:\/\/doi.org\/10.1016\/j.neuint.2017.01.004.","journal-title":"Neurochem Int"},{"key":"1499_CR66","doi-asserted-by":"publisher","unstructured":"Agostini F, Bubacco L, Chakrabarti S, Bisaglia M. \u03b1-Synuclein toxicity in drosophila melanogaster is enhanced by the presence of iron: implications for Parkinson\u2019s disease. Antioxidants. 2023; 12:https:\/\/doi.org\/10.3390\/antiox12020261.","DOI":"10.3390\/antiox12020261"},{"key":"1499_CR67","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1016\/j.neubiorev.2020.10.004","volume":"120","author":"G Bj\u00f8rklund","year":"2021","unstructured":"Bj\u00f8rklund G, Peana M, Maes M, Dadar M, Severin B. The glutathione system in Parkinson\u2019s disease and its progression. Neurosci Biobehav Rev. 2021;120:470\u20138. https:\/\/doi.org\/10.1016\/j.neubiorev.2020.10.004.","journal-title":"Neurosci Biobehav Rev"},{"key":"1499_CR68","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1002\/ana.410360305","volume":"36","author":"J Sian","year":"1994","unstructured":"Sian J, Dexter DT, Lees AJ, Daniel S, Agid Y, Javoy-Agid F, et al. Alterations in glutathione levels in Parkinson\u2019s disease and other neurodegenerative disorders affecting basal ganglia. Ann Neurol. 1994;36:348\u201355. https:\/\/doi.org\/10.1002\/ana.410360305.","journal-title":"Ann Neurol"},{"key":"1499_CR69","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1007\/s11064-021-03262-9","volume":"46","author":"X Zeng","year":"2021","unstructured":"Zeng X, An H, Yu F, Wang K, Zheng L, Zhou W, et al. Benefits of iron chelators in the treatment of Parkinson\u2019s disease. Neurochem Res. 2021;46:1239\u201351. https:\/\/doi.org\/10.1007\/s11064-021-03262-9.","journal-title":"Neurochem Res"},{"key":"1499_CR70","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1046\/j.1471-4159.2002.01118.x","volume":"83","author":"BA Faucheux","year":"2002","unstructured":"Faucheux BA, Martin ME, Beaumont C, Hunot S, Hauw JJ, Agid Y, et al. Lack of up-regulation of ferritin is associated with sustained iron regulatory protein-1 binding activity in the substantia nigra of patients with Parkinson\u2019s disease. J Neurochem. 2002;83:320\u201330. https:\/\/doi.org\/10.1046\/j.1471-4159.2002.01118.x.","journal-title":"J Neurochem"},{"key":"1499_CR71","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.molcel.2015.06.011","volume":"59","author":"M Gao","year":"2015","unstructured":"Gao M, Monian P, Quadri N, Ramasamy R, Jiang X. Glutaminolysis and transferrin regulate ferroptosis. Mol Cell. 2015;59:298\u2013308. https:\/\/doi.org\/10.1016\/j.molcel.2015.06.011.","journal-title":"Mol Cell"},{"key":"1499_CR72","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1038\/s41586-019-1705-2","volume":"575","author":"K Bersuker","year":"2019","unstructured":"Bersuker K, Hendricks JM, Li Z, Magtanong L, Ford B, Tang PH, et al. The CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit ferroptosis. Nature. 2019;575:688\u201392. https:\/\/doi.org\/10.1038\/s41586-019-1705-2.","journal-title":"Nature"},{"key":"1499_CR73","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/nchembio.2239","volume":"13","author":"S Doll","year":"2017","unstructured":"Doll S, Proneth B, Tyurina YY, Panzilius E, Kobayashi S, Ingold I, et al. ACSL4 dictates ferroptosis sensitivity by shaping cellular lipid composition. Nat Chem Biol. 2017;13:91\u201398. https:\/\/doi.org\/10.1038\/nchembio.2239.","journal-title":"Nat Chem Biol"},{"key":"1499_CR74","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1016\/j.bbrc.2016.08.124","volume":"478","author":"H Yuan","year":"2016","unstructured":"Yuan H, Li X, Zhang X, Kang R, Tang D. Identification of ACSL4 as a biomarker and contributor of ferroptosis. Biochem Biophys Res Commun. 2016;478:1338\u201343. https:\/\/doi.org\/10.1016\/j.bbrc.2016.08.124.","journal-title":"Biochem Biophys Res Commun"},{"key":"1499_CR75","doi-asserted-by":"publisher","unstructured":"Yue M, Wei J, Chen W, Hong D, Chen T, Fang X. Neurotrophic role of the next-generation probiotic Strain L. lactis MG1363-pMG36e-GLP-1 on Parkinson\u2019s disease via inhibiting ferroptosis. Nutrients. 2022; 14:https:\/\/doi.org\/10.3390\/nu14224886.","DOI":"10.3390\/nu14224886"},{"key":"1499_CR76","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2021.102431","volume":"24","author":"LM Song","year":"2021","unstructured":"Song LM, Xiao ZX, Zhang N, Yu XQ, Cui W, Xie JX, et al. Apoferritin improves motor deficits in MPTP-treated mice by regulating brain iron metabolism and ferroptosis. iScience. 2021;24:102431. https:\/\/doi.org\/10.1016\/j.isci.2021.102431.","journal-title":"iScience"},{"key":"1499_CR77","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.727762","volume":"9","author":"ZW Hu","year":"2021","unstructured":"Hu ZW, Wen YH, Ma RQ, Chen L, Zeng XL, Wen WP, et al. Ferroptosis Driver SOCS1 and Suppressor FTH1 independently correlate with M1 and M2 macrophage infiltration in head and neck squamous cell carcinoma. Front Cell Dev Biol. 2021;9:727762. https:\/\/doi.org\/10.3389\/fcell.2021.727762.","journal-title":"Front Cell Dev Biol"},{"key":"1499_CR78","doi-asserted-by":"publisher","first-page":"1796","DOI":"10.1007\/s13311-020-00929-z","volume":"17","author":"Y Tian","year":"2020","unstructured":"Tian Y, Lu J, Hao X, Li H, Zhang G, Liu X, et al. FTH1 inhibits ferroptosis through ferritinophagy in the 6-OHDA model of Parkinson\u2019s disease. Neurotherapeutics. 2020;17:1796\u2013812. https:\/\/doi.org\/10.1007\/s13311-020-00929-z.","journal-title":"Neurotherapeutics"},{"key":"1499_CR79","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1007\/s10863-016-9669-5","volume":"48","author":"CQ Dai","year":"2016","unstructured":"Dai CQ, Luo TT, Luo SC, Wang JQ, Wang SM, Bai YH, et al. p53 and mitochondrial dysfunction: novel insight of neurodegenerative diseases. J Bioenerg Biomembr. 2016;48:337\u201347. https:\/\/doi.org\/10.1007\/s10863-016-9669-5.","journal-title":"J Bioenerg Biomembr"},{"key":"1499_CR80","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1038\/s41418-017-0016-0","volume":"25","author":"T Goiran","year":"2018","unstructured":"Goiran T, Duplan E, Rouland L, El Manaa W, Lauritzen I, Dunys J, et al. Nuclear p53-mediated repression of autophagy involves PINK1 transcriptional down-regulation. Cell Death Differ. 2018;25:873\u201384. https:\/\/doi.org\/10.1038\/s41418-017-0016-0.","journal-title":"Cell Death Differ"},{"key":"1499_CR81","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1038\/s41586-020-1996-3","volume":"578","author":"M Amit","year":"2020","unstructured":"Amit M, Takahashi H, Dragomir MP, Lindemann A, Gleber-Netto FO, Pickering CR, et al. Loss of p53 drives neuron reprogramming in head and neck cancer. Nature. 2020;578:449\u201354. https:\/\/doi.org\/10.1038\/s41586-020-1996-3.","journal-title":"Nature"},{"key":"1499_CR82","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.neulet.2006.12.003","volume":"414","author":"M Mogi","year":"2007","unstructured":"Mogi M, Kondo T, Mizuno Y, Nagatsu T. p53 protein, interferon-gamma, and NF-kappaB levels are elevated in the Parkinsonian brain. Neurosci Lett. 2007;414:94\u20137. https:\/\/doi.org\/10.1016\/j.neulet.2006.12.003.","journal-title":"Neurosci Lett"},{"key":"1499_CR83","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1038\/s41593-022-01061-1","volume":"25","author":"T Kamath","year":"2022","unstructured":"Kamath T, Abdulraouf A, Burris SJ, Langlieb J, Gazestani V, Nadaf NM, et al. Single-cell genomic profiling of human dopamine neurons identifies a population that selectively degenerates in Parkinson\u2019s disease. Nat Neurosci. 2022;25:588\u201395. https:\/\/doi.org\/10.1038\/s41593-022-01061-1.","journal-title":"Nat Neurosci"},{"key":"1499_CR84","doi-asserted-by":"publisher","first-page":"12387","DOI":"10.1016\/S0021-9258(18)43284-X","volume":"256","author":"T Ishii","year":"1981","unstructured":"Ishii T, Bannai S, Sugita Y. Mechanism of growth stimulation of L1210 cells by 2-mercaptoethanol in vitro. Role of the mixed disulfide of 2-mercaptoethanol and cysteine. J Biol Chem. 1981;256:12387\u201392.","journal-title":"J Biol Chem"},{"key":"1499_CR85","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/nature14344","volume":"520","author":"L Jiang","year":"2015","unstructured":"Jiang L, Kon N, Li T, Wang SJ, Su T, Hibshoosh H, et al. Ferroptosis as a p53-mediated activity during tumour suppression. Nature. 2015;520:57\u201362. https:\/\/doi.org\/10.1038\/nature14344.","journal-title":"Nature"},{"key":"1499_CR86","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2024.216671","volume":"585","author":"G Riegel","year":"2024","unstructured":"Riegel G, Orvain C, Recberlik S, Spaety ME, Poschet G, Venkatasamy A, et al. The unfolded protein response-glutathione metabolism axis: a novel target of a cycloruthenated complexes bypassing tumor resistance mechanisms. Cancer Lett. 2024;585:216671. https:\/\/doi.org\/10.1016\/j.canlet.2024.216671.","journal-title":"Cancer Lett"},{"key":"1499_CR87","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.1021\/acschembio.5b00245","volume":"10","author":"SJ Dixon","year":"2015","unstructured":"Dixon SJ, Winter GE, Musavi LS, Lee ED, Snijder B, Rebsamen M, et al. Human haploid cell genetics reveals roles for lipid metabolism genes in nonapoptotic cell death. ACS Chem Biol. 2015;10:1604\u20139. https:\/\/doi.org\/10.1021\/acschembio.5b00245.","journal-title":"ACS Chem Biol"},{"key":"1499_CR88","doi-asserted-by":"publisher","first-page":"477","DOI":"10.2174\/1573406413666170421102353","volume":"13","author":"M Skonieczna","year":"2017","unstructured":"Skonieczna M, Cieslar-Pobuda A, Saenko Y, Foksinski M, Olinski R, Rzeszowska-Wolny J, et al. The Impact of DIDS-Induced Inhibition of Voltage-Dependent Anion Channels (VDAC) on cellular response of lymphoblastoid cells to ionizing radiation. Med Chem. 2017;13:477\u201383. https:\/\/doi.org\/10.2174\/1573406413666170421102353.","journal-title":"Med Chem"},{"key":"1499_CR89","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.bbalip.2014.10.002","volume":"1851","author":"H Kuhn","year":"2015","unstructured":"Kuhn H, Banthiya S, van Leyen K. Mammalian lipoxygenases and their biological relevance. Biochim Biophys Acta. 2015;1851:308\u201330. https:\/\/doi.org\/10.1016\/j.bbalip.2014.10.002.","journal-title":"Biochim Biophys Acta"},{"key":"1499_CR90","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-022-04708-w","volume":"13","author":"F Lin","year":"2022","unstructured":"Lin F, Chen W, Zhou J, Zhu J, Yao Q, Feng B, et al. Mesenchymal stem cells protect against ferroptosis via exosome-mediated stabilization of SLC7A11 in acute liver injury. Cell Death Dis. 2022;13:271. https:\/\/doi.org\/10.1038\/s41419-022-04708-w.","journal-title":"Cell Death Dis"},{"key":"1499_CR91","doi-asserted-by":"publisher","DOI":"10.1016\/j.prostaglandins.2021.106587","volume":"157","author":"SM Razavi","year":"2021","unstructured":"Razavi SM, Khayatan D, Arab ZN, Momtaz S, Zare K, Jafari RM, et al. Licofelone, a potent COX\/5-LOX inhibitor and a novel option for treatment of neurological disorders. Prostagl Other Lipid Mediat. 2021;157:106587. https:\/\/doi.org\/10.1016\/j.prostaglandins.2021.106587.","journal-title":"Prostagl Other Lipid Mediat"},{"key":"1499_CR92","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1038\/s41593-022-01221-3","volume":"26","author":"SK Ryan","year":"2023","unstructured":"Ryan SK, Zelic M, Han Y, Teeple E, Chen L, Sadeghi M, et al. Microglia ferroptosis is regulated by SEC24B and contributes to neurodegeneration. Nat Neurosci. 2023;26:12\u201326. https:\/\/doi.org\/10.1038\/s41593-022-01221-3.","journal-title":"Nat Neurosci"},{"key":"1499_CR93","doi-asserted-by":"publisher","first-page":"6395","DOI":"10.1007\/s12035-023-03468-8","volume":"60","author":"H Lu","year":"2023","unstructured":"Lu H, Zhang B, Yin T, Hua Y, Cao C, Ge M, et al. Ferroptosis-related immune genes in hematological diagnosis of Parkinson\u2019s diseases. Mol Neurobiol. 2023;60:6395\u2013409. https:\/\/doi.org\/10.1007\/s12035-023-03468-8.","journal-title":"Mol Neurobiol"},{"key":"1499_CR94","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2023.106779","volume":"193","author":"K Li","year":"2023","unstructured":"Li K, Wang M, Huang Z-H, Wang M, Sun W-Y, Kurihara H, et al. ALOX5 inhibition protects against dopaminergic neurons undergoing ferroptosis. Pharmacol Res. 2023;193:106779. https:\/\/doi.org\/10.1016\/j.phrs.2023.106779.","journal-title":"Pharmacol Res"},{"key":"1499_CR95","doi-asserted-by":"publisher","first-page":"9515","DOI":"10.18632\/aging.103225","volume":"12","author":"L Shi","year":"2020","unstructured":"Shi L, Huang C, Luo Q, Xia Y, Liu W, Zeng W, et al. Clioquinol improves motor and non-motor deficits in MPTP-induced monkey model of Parkinson\u2019s disease through AKT\/mTOR pathway. Aging. 2020;12:9515\u201333. https:\/\/doi.org\/10.18632\/aging.103225.","journal-title":"Aging"},{"key":"1499_CR96","doi-asserted-by":"publisher","first-page":"7885","DOI":"10.1039\/d2fo00357k","volume":"13","author":"Y Sun","year":"2022","unstructured":"Sun Y, He L, Wang W, Xie Z, Zhang X, Wang P, et al. Activation of Atg7-dependent autophagy by a novel inhibitor of the Keap1-Nrf2 protein-protein interaction from Penthorum Chinense Pursh. attenuates 6-hydroxydopamine-induced ferroptosis in zebrafish and dopaminergic neurons. Food Funct. 2022;13:7885\u20137900. https:\/\/doi.org\/10.1039\/d2fo00357k.","journal-title":"Food Funct"},{"key":"1499_CR97","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.freeradbiomed.2022.08.011","volume":"190","author":"J Xi","year":"2022","unstructured":"Xi J, Zhang Z, Wang Z, Wu Q, He Y, Xu Y, et al. Hinokitiol functions as a ferroptosis inhibitor to confer neuroprotection. Free Radic Biol Med. 2022;190:202\u201315. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2022.08.011.","journal-title":"Free Radic Biol Med"},{"key":"1499_CR98","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchemneu.2022.102103","volume":"122","author":"L Wang","year":"2022","unstructured":"Wang L, An H, Yu F, Yang J, Ding H, Bao Y, et al. The neuroprotective effects of paeoniflorin against MPP+-induced damage to dopaminergic neurons via the Akt\/Nrf2\/GPX4 pathway. J Chem Neuroanat. 2022;122:102103. https:\/\/doi.org\/10.1016\/j.jchemneu.2022.102103.","journal-title":"J Chem Neuroanat"},{"key":"1499_CR99","doi-asserted-by":"publisher","first-page":"4628","DOI":"10.1007\/s12035-020-02049-3","volume":"57","author":"Y Sun","year":"2020","unstructured":"Sun Y, He L, Wang T, Hua W, Qin H, Wang J, et al. Activation of p62-Keap1-Nrf2 Pathway Protects 6-Hydroxydopamine-Induced ferroptosis in dopaminergic cells. Mol Neurobiol. 2020;57:4628\u201341. https:\/\/doi.org\/10.1007\/s12035-020-02049-3.","journal-title":"Mol Neurobiol"},{"key":"1499_CR100","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1002\/cbin.11505","volume":"45","author":"L Liu","year":"2021","unstructured":"Liu L, Yang S, Wang H. \u03b1-Lipoic acid alleviates ferroptosis in the MPP+-induced PC12 cells via activating the PI3K\/Akt\/Nrf2 pathway. Cell Biol Int. 2021;45:422\u201331. https:\/\/doi.org\/10.1002\/cbin.11505.","journal-title":"Cell Biol Int"},{"key":"1499_CR101","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1021\/acsbiomedchemau.3c00066","volume":"4","author":"N Marupudi","year":"2024","unstructured":"Marupudi N, Xiong MP. Genetic targets and applications of iron chelators for neurodegeneration with brain iron accumulation. ACS Bio Med Chem Au. 2024;4:119\u201330. https:\/\/doi.org\/10.1021\/acsbiomedchemau.3c00066.","journal-title":"ACS Bio Med Chem Au"},{"key":"1499_CR102","doi-asserted-by":"publisher","DOI":"10.1111\/cns.14607","volume":"30","author":"A Negida","year":"2024","unstructured":"Negida A, Hassan NM, Aboeldahab H, Zain YE, Negida Y, Cadri S, et al. Efficacy of the iron-chelating agent, deferiprone, in patients with Parkinson\u2019s disease: A systematic review and meta-analysis. CNS Neurosci Ther. 2024;30:e14607. https:\/\/doi.org\/10.1111\/cns.14607.","journal-title":"CNS Neurosci Ther"},{"key":"1499_CR103","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/j.cell.2007.02.006","volume":"128","author":"AD Goldberg","year":"2007","unstructured":"Goldberg AD, Allis CD, Bernstein E. Epigenetics: a landscape takes shape. Cell. 2007;128:635\u20138. https:\/\/doi.org\/10.1016\/j.cell.2007.02.006.","journal-title":"Cell"},{"key":"1499_CR104","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/978-81-15-3449-2_1","volume":"1253","author":"L Zhang","year":"2020","unstructured":"Zhang L, Lu Q, Chang C. Epigenetics in health and disease. Adv Exp Med Biol. 2020;1253:3\u201355. https:\/\/doi.org\/10.1007\/978-81-15-3449-2_1.","journal-title":"Adv Exp Med Biol"},{"key":"1499_CR105","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1016\/j.arcmed.2022.11.003","volume":"53","author":"F Recillas-Targa","year":"2022","unstructured":"Recillas-Targa F. Cancer epigenetics: an overview. Arch Med Res. 2022;53:732\u201340. https:\/\/doi.org\/10.1016\/j.arcmed.2022.11.003.","journal-title":"Arch Med Res"},{"key":"1499_CR106","doi-asserted-by":"publisher","DOI":"10.1161\/jaha.121.025163","volume":"11","author":"G Wang","year":"2022","unstructured":"Wang G, Wang B, Yang P. Epigenetics in congenital heart disease. J Am Heart Assoc. 2022;11:e025163. https:\/\/doi.org\/10.1161\/jaha.121.025163.","journal-title":"J Am Heart Assoc"},{"key":"1499_CR107","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1139\/bcb-2019-0045","volume":"98","author":"D Prasher","year":"2020","unstructured":"Prasher D, Greenway SC, Singh RB. The impact of epigenetics on cardiovascular disease. Biochem Cell Biol. 2020;98:12\u201322. https:\/\/doi.org\/10.1139\/bcb-2019-0045.","journal-title":"Biochem Cell Biol"},{"key":"1499_CR108","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1016\/j.cmet.2019.03.009","volume":"29","author":"C Ling","year":"2019","unstructured":"Ling C, R\u00f6nn T. Epigenetics in human obesity and type 2 diabetes. Cell Metab. 2019;29:1028\u201344. https:\/\/doi.org\/10.1016\/j.cmet.2019.03.009.","journal-title":"Cell Metab"},{"key":"1499_CR109","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2022.911635","volume":"14","author":"X Gao","year":"2022","unstructured":"Gao X, Chen Q, Yao H, Tan J, Liu Z, Zhou Y, et al. Epigenetics in Alzheimer\u2019s disease. Front Aging Neurosci. 2022;14:911635. https:\/\/doi.org\/10.3389\/fnagi.2022.911635.","journal-title":"Front Aging Neurosci"},{"key":"1499_CR110","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2024.176641","volume":"975","author":"R Sharma","year":"2024","unstructured":"Sharma R, Bisht P, Kesharwani A, Murti K, Kumar N. Epigenetic modifications in Parkinson\u2019s disease: A critical review. Eur J Pharmacol. 2024;975:176641. https:\/\/doi.org\/10.1016\/j.ejphar.2024.176641.","journal-title":"Eur J Pharmacol"},{"key":"1499_CR111","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1038\/s41582-023-00811-4","volume":"19","author":"JM Burgunder","year":"2023","unstructured":"Burgunder JM. Mechanisms underlying phenotypic variation in neurogenetic disorders. Nat Rev Neurol. 2023;19:363\u201370. https:\/\/doi.org\/10.1038\/s41582-023-00811-4.","journal-title":"Nat Rev Neurol"},{"key":"1499_CR112","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/j.tins.2018.05.005","volume":"41","author":"A Berson","year":"2018","unstructured":"Berson A, Nativio R, Berger SL, Bonini NM. Epigenetic regulation in neurodegenerative diseases. Trends Neurosci. 2018;41:587\u201398. https:\/\/doi.org\/10.1016\/j.tins.2018.05.005.","journal-title":"Trends Neurosci"},{"key":"1499_CR113","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-41033-y","volume":"14","author":"J Li","year":"2023","unstructured":"Li J, Jaiswal MK, Chien JF, Kozlenkov A, Jung J, Zhou P, et al. Divergent single cell transcriptome and epigenome alterations in ALS and FTD patients with C9orf72 mutation. Nat Commun. 2023;14:5714. https:\/\/doi.org\/10.1038\/s41467-023-41033-y.","journal-title":"Nat Commun"},{"key":"1499_CR114","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/S0021-9258(18)57261-6","volume":"175","author":"RD Hotchkiss","year":"1948","unstructured":"Hotchkiss RD. The quantitative separation of purines, pyrimidines, and nucleosides by paper chromatography. J Biol Chem. 1948;175:315\u201332.","journal-title":"J Biol Chem"},{"key":"1499_CR115","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-024-03207-9","volume":"25","author":"BD Sigurpalsdottir","year":"2024","unstructured":"Sigurpalsdottir BD, Stefansson OA, Holley G, Beyter D, Zink F, Hardarson M, et al. A comparison of methods for detecting DNA methylation from long-read sequencing of human genomes. Genome Biol. 2024;25:69. https:\/\/doi.org\/10.1186\/s13059-024-03207-9.","journal-title":"Genome Biol"},{"key":"1499_CR116","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.brainres.2013.08.005","volume":"1533","author":"RK Simmons","year":"2013","unstructured":"Simmons RK, Stringfellow SA, Glover ME, Wagle AA, Clinton SM. DNA methylation markers in the postnatal developing rat brain. Brain Res. 2013;1533:26\u201336. https:\/\/doi.org\/10.1016\/j.brainres.2013.08.005.","journal-title":"Brain Res"},{"key":"1499_CR117","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1016\/j.apsb.2021.11.002","volume":"12","author":"Y He","year":"2022","unstructured":"He Y, Zheng Z, Liu C, Li W, Zhao L, Nie G, et al. Inhibiting DNA methylation alleviates cisplatin-induced hearing loss by decreasing oxidative stress-induced mitochondria-dependent apoptosis via the LRP1-PI3K\/AKT pathway. Acta Pharm Sin B. 2022;12:1305\u201321. https:\/\/doi.org\/10.1016\/j.apsb.2021.11.002.","journal-title":"Acta Pharm Sin B"},{"key":"1499_CR118","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1093\/bfgp\/elw017","volume":"15","author":"M Suelves","year":"2016","unstructured":"Suelves M, Carri\u00f3 E, N\u00fa\u00f1ez-\u00c1lvarez Y, Peinado MA. DNA methylation dynamics in cellular commitment and differentiation. Brief Funct Genomics. 2016;15:443\u201353. https:\/\/doi.org\/10.1093\/bfgp\/elw017.","journal-title":"Brief Funct Genomics"},{"key":"1499_CR119","doi-asserted-by":"publisher","first-page":"6355","DOI":"10.1523\/jneurosci.6119-09.2010","volume":"30","author":"A Jowaed","year":"2010","unstructured":"Jowaed A, Schmitt I, Kaut O, W\u00fcllner U. Methylation regulates alpha-synuclein expression and is decreased in Parkinson\u2019s disease patients\u2019 brains. J Neurosci. 2010;30:6355\u20139. https:\/\/doi.org\/10.1523\/jneurosci.6119-09.2010.","journal-title":"J Neurosci"},{"key":"1499_CR120","doi-asserted-by":"publisher","unstructured":"Schmitt I, Evert BO, Sharma A, Khazneh H, Murgatroyd C, W\u00fcllner U. The Alpha-Synuclein Gene (SNCA) is a genomic target of methyl-CpG Binding Protein 2 (MeCP2)-implications for Parkinson\u2019s disease and Rett syndrome. Mol Neurobiol. 2024. https:\/\/doi.org\/10.1007\/s12035-024-03974-3.","DOI":"10.1007\/s12035-024-03974-3"},{"key":"1499_CR121","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/ng.3522","volume":"48","author":"O Bogdanovi\u0107","year":"2016","unstructured":"Bogdanovi\u0107 O, Smits AH, de la Calle Mustienes E, Tena JJ, Ford E, Williams R, et al. Active DNA demethylation at enhancers during the vertebrate phylotypic period. Nat Genet. 2016;48:417\u201326. https:\/\/doi.org\/10.1038\/ng.3522.","journal-title":"Nat Genet"},{"key":"1499_CR122","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1038\/s41392-023-01537-x","volume":"8","author":"X Zhang","year":"2023","unstructured":"Zhang X, Zhang Y, Wang C, Wang X. TET (Ten-eleven translocation) family proteins: structure, biological functions and applications. Signal Transduct Target Ther. 2023;8:297. https:\/\/doi.org\/10.1038\/s41392-023-01537-x.","journal-title":"Signal Transduct Target Ther"},{"key":"1499_CR123","doi-asserted-by":"publisher","first-page":"S85","DOI":"10.5213\/inj.2222206.103","volume":"26","author":"S Guhathakurta","year":"2022","unstructured":"Guhathakurta S, Song MK, Basu S, Je G, Cristovao AC, Kim YS. Regulation of \u03b1lpha-synuclein gene (SNCA) by epigenetic modifier TET1 in Parkinson disease. Int Neurourol J. 2022;26:S85\u201393. https:\/\/doi.org\/10.5213\/inj.2222206.103.","journal-title":"Int Neurourol J"},{"key":"1499_CR124","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1016\/j.neuron.2013.08.032","volume":"79","author":"GA Kaas","year":"2013","unstructured":"Kaas GA, Zhong C, Eason DE, Ross DL, Vachhani RV, Ming GL, et al. TET1 controls CNS 5-methylcytosine hydroxylation, active DNA demethylation, gene transcription, and memory formation. Neuron. 2013;79:1086\u201393. https:\/\/doi.org\/10.1016\/j.neuron.2013.08.032.","journal-title":"Neuron"},{"key":"1499_CR125","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.jad.2022.04.087","volume":"310","author":"Y Li","year":"2022","unstructured":"Li Y, Qu C, Song H, Li T, Zheng J, Wu L, et al. Enriched environment priors to TET1 hippocampal administration for regulating psychiatric behaviors via glial reactivity in chronic cerebral hypoperfusion models. J Affect Disord. 2022;310:198\u2013212. https:\/\/doi.org\/10.1016\/j.jad.2022.04.087.","journal-title":"J Affect Disord"},{"key":"1499_CR126","doi-asserted-by":"publisher","first-page":"242.e13","DOI":"10.1016\/j.neurobiolaging.2019.02.025","volume":"84","author":"L Shu","year":"2019","unstructured":"Shu L, Qin L, Min S, Pan H, Zhong J, Guo J, et al. Genetic analysis of DNA methylation and hydroxymethylation genes in Parkinson\u2019s disease. Neurobiol Aging. 2019;84:242.e13\u2013242.e16. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2019.02.025.","journal-title":"Neurobiol Aging"},{"key":"1499_CR127","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s10048-016-0497-x","volume":"18","author":"O Kaut","year":"2017","unstructured":"Kaut O, Schmitt I, Tost J, Busato F, Liu Y, Hofmann P, et al. Epigenome-wide DNA methylation analysis in siblings and monozygotic twins discordant for sporadic Parkinson\u2019s disease revealed different epigenetic patterns in peripheral blood mononuclear cells. Neurogenetics. 2017;18:7\u201322. https:\/\/doi.org\/10.1007\/s10048-016-0497-x.","journal-title":"Neurogenetics"},{"key":"1499_CR128","doi-asserted-by":"publisher","first-page":"591","DOI":"10.3390\/biology4030591","volume":"4","author":"C Bate","year":"2015","unstructured":"Bate C, Williams A. cAMP-inhibits cytoplasmic phospholipase A2 and protects neurons against Amyloid-\u03b2-induced synapse damage. Biology. 2015;4:591\u2013606. https:\/\/doi.org\/10.3390\/biology4030591.","journal-title":"Biology"},{"key":"1499_CR129","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.adg9504","volume":"16","author":"VV Gurevich","year":"2023","unstructured":"Gurevich VV, Gurevich EV. A boost in learning by removing nuclear phosphodiesterases and enhancing nuclear cAMP signaling. Sci Signal. 2023;16:eadg9504. https:\/\/doi.org\/10.1126\/scisignal.adg9504.","journal-title":"Sci Signal"},{"key":"1499_CR130","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s40035-021-00232-7","volume":"10","author":"X Morat\u00f3","year":"2021","unstructured":"Morat\u00f3 X, Garcia-Esparcia P, Argerich J, Llorens F, Zerr I, Paslawski W, et al. Ecto-GPR37: a potential biomarker for Parkinson\u2019s disease. Transl Neurodegener. 2021;10:8. https:\/\/doi.org\/10.1186\/s40035-021-00232-7.","journal-title":"Transl Neurodegener"},{"key":"1499_CR131","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1038\/ng.487","volume":"41","author":"J Sim\u00f3n-S\u00e1nchez","year":"2009","unstructured":"Sim\u00f3n-S\u00e1nchez J, Schulte C, Bras JM, Sharma M, Gibbs JR, Berg D, et al. Genome-wide association study reveals genetic risk underlying Parkinson\u2019s disease. Nat Genet. 2009;41:1308\u201312. https:\/\/doi.org\/10.1038\/ng.487.","journal-title":"Nat Genet"},{"key":"1499_CR132","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/s0197-4580(00)00202-5","volume":"22","author":"LA Reed","year":"2001","unstructured":"Reed LA, Wszolek ZK, Hutton M. Phenotypic correlations in FTDP-17. Neurobiol Aging. 2001;22:89\u2013107. https:\/\/doi.org\/10.1016\/s0197-4580(00)00202-5.","journal-title":"Neurobiol Aging"},{"key":"1499_CR133","doi-asserted-by":"publisher","first-page":"4349","DOI":"10.1093\/brain\/awac325","volume":"145","author":"MPM Soutar","year":"2022","unstructured":"Soutar MPM, Melandri D, O\u2019Callaghan B, Annuario E, Monaghan AE, Welsh NJ, et al. Regulation of mitophagy by the NSL complex underlies genetic risk for Parkinson\u2019s disease at 16q11.2 and MAPT H1 loci. Brain. 2022;145:4349\u201367. https:\/\/doi.org\/10.1093\/brain\/awac325.","journal-title":"Brain"},{"key":"1499_CR134","doi-asserted-by":"publisher","first-page":"e0134087","DOI":"10.1371\/journal.pone.0134087","volume":"10","author":"X Su","year":"2015","unstructured":"Su X, Chu Y, Kordower JH, Li B, Cao H, Huang L, et al. PGC-1\u03b1 promoter methylation in Parkinson\u2019s disease. PLoS One. 2015;10:e0134087. https:\/\/doi.org\/10.1371\/journal.pone.0134087.","journal-title":"PLoS One."},{"key":"1499_CR135","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2021.640266","volume":"12","author":"AR Henderson","year":"2021","unstructured":"Henderson AR, Wang Q, Meechoovet B, Siniard AL, Naymik M, De Both M, et al. DNA methylation and expression profiles of whole blood in Parkinson\u2019s disease. Front Genet. 2021;12:640266. https:\/\/doi.org\/10.3389\/fgene.2021.640266.","journal-title":"Front Genet"},{"key":"1499_CR136","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1038\/s41531-022-00355-2","volume":"8","author":"J Kochmanski","year":"2022","unstructured":"Kochmanski J, Kuhn NC, Bernstein AI. Parkinson\u2019s disease-associated, sex-specific changes in DNA methylation at PARK7 (DJ-1), SLC17A6 (VGLUT2), PTPRN2 (IA-2\u03b2), and NR4A2 (NURR1) in cortical neurons. NPJ Park Dis. 2022;8:120. https:\/\/doi.org\/10.1038\/s41531-022-00355-2.","journal-title":"NPJ Park Dis"},{"key":"1499_CR137","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.neulet.2011.12.007","volume":"507","author":"Q Lin","year":"2012","unstructured":"Lin Q, Ding H, Zheng Z, Gu Z, Ma J, Chen L, et al. Promoter methylation analysis of seven clock genes in Parkinson\u2019s disease. Neurosci Lett. 2012;507:147\u201350. https:\/\/doi.org\/10.1016\/j.neulet.2011.12.007.","journal-title":"Neurosci Lett"},{"key":"1499_CR138","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s10048-011-0308-3","volume":"13","author":"O Kaut","year":"2012","unstructured":"Kaut O, Schmitt I, W\u00fcllner U. Genome-scale methylation analysis of Parkinson\u2019s disease patients\u2019 brains reveals DNA hypomethylation and increased mRNA expression of cytochrome P450 2E1. Neurogenetics. 2012;13:87\u201391. https:\/\/doi.org\/10.1007\/s10048-011-0308-3","journal-title":"Neurogenetics"},{"key":"1499_CR139","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.parkreldis.2015.01.007","volume":"21","author":"S Searles Nielsen","year":"2015","unstructured":"Searles Nielsen S, Checkoway H, Criswell SR, Farin FM, Stapleton PL, Sheppard L, et al. Inducible nitric oxide synthase gene methylation and parkinsonism in manganese-exposed welders. Parkinsonism Relat Disord. 2015;21:355\u201360. https:\/\/doi.org\/10.1016\/j.parkreldis.2015.01.007.","journal-title":"Parkinsonism Relat Disord"},{"key":"1499_CR140","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1038\/38444","volume":"389","author":"K Luger","year":"1997","unstructured":"Luger K, M\u00e4der AW, Richmond RK, Sargent DF, Richmond TJ. Crystal structure of the nucleosome core particle at 2.8 A resolution. Nature. 1997;389:251\u201360. https:\/\/doi.org\/10.1038\/38444.","journal-title":"Nature"},{"key":"1499_CR141","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/j.molcel.2008.02.014","volume":"29","author":"VM Weake","year":"2008","unstructured":"Weake VM, Workman JL. Histone ubiquitination: triggering gene activity. Mol Cell. 2008;29:653\u201363. https:\/\/doi.org\/10.1016\/j.molcel.2008.02.014.","journal-title":"Mol Cell"},{"key":"1499_CR142","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/cr.2011.22","volume":"21","author":"AJ Bannister","year":"2011","unstructured":"Bannister AJ, Kouzarides T. Regulation of chromatin by histone modifications. Cell Res. 2011;21:381\u201395. https:\/\/doi.org\/10.1038\/cr.2011.22.","journal-title":"Cell Res"},{"key":"1499_CR143","doi-asserted-by":"publisher","first-page":"4736","DOI":"10.1016\/j.molcel.2021.09.019","volume":"81","author":"S Gopalan","year":"2021","unstructured":"Gopalan S, Wang Y, Harper NW, Garber M, Fazzio TG. Simultaneous profiling of multiple chromatin proteins in the same cells. Mol Cell. 2021;81:4736\u2013.e5. https:\/\/doi.org\/10.1016\/j.molcel.2021.09.019.","journal-title":"Mol Cell"},{"key":"1499_CR144","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1038\/s41587-022-01535-4","volume":"41","author":"M Bartosovic","year":"2023","unstructured":"Bartosovic M, Castelo-Branco G. Multimodal chromatin profiling using nanobody-based single-cell CUT&Tag. Nat Biotechnol. 2023;41:794\u2013805. https:\/\/doi.org\/10.1038\/s41587-022-01535-4.","journal-title":"Nat Biotechnol"},{"key":"1499_CR145","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1038\/s41587-022-01522-9","volume":"41","author":"MP Meers","year":"2023","unstructured":"Meers MP, Llagas G, Janssens DH, Codomo CA, Henikoff S. Multifactorial profiling of epigenetic landscapes at single-cell resolution using MulTI-Tag. Nat Biotechnol. 2023;41:708\u201316. https:\/\/doi.org\/10.1038\/s41587-022-01522-9.","journal-title":"Nat Biotechnol"},{"key":"1499_CR146","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1038\/s41587-022-01588-5","volume":"41","author":"T Stuart","year":"2023","unstructured":"Stuart T, Hao S, Zhang B, Mekerishvili L, Landau DA, Maniatis S, et al. Nanobody-tethered transposition enables multifactorial chromatin profiling at single-cell resolution. Nat Biotechnol. 2023;41:806\u201312. https:\/\/doi.org\/10.1038\/s41587-022-01588-5.","journal-title":"Nat Biotechnol"},{"key":"1499_CR147","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adi3664","volume":"10","author":"H Xiong","year":"2024","unstructured":"Xiong H, Wang Q, Li CC, He A. Single-cell joint profiling of multiple epigenetic proteins and gene transcription. Sci Adv. 2024;10:eadi3664. https:\/\/doi.org\/10.1126\/sciadv.adi3664.","journal-title":"Sci Adv"},{"key":"1499_CR148","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-35650-2","volume":"13","author":"X Yue","year":"2022","unstructured":"Yue X, Xie Z, Li M, Wang K, Li X, Zhang X, et al. Simultaneous profiling of histone modifications and DNA methylation via nanopore sequencing. Nat Commun. 2022;13:7939. https:\/\/doi.org\/10.1038\/s41467-022-35650-2.","journal-title":"Nat Commun"},{"key":"1499_CR149","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1038\/nrg2540","volume":"10","author":"H Cedar","year":"2009","unstructured":"Cedar H, Bergman Y. Linking DNA methylation and histone modification: patterns and paradigms. Nat Rev Genet. 2009;10:295\u2013304. https:\/\/doi.org\/10.1038\/nrg2540.","journal-title":"Nat Rev Genet"},{"key":"1499_CR150","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/j.cell.2007.02.005","volume":"128","author":"T Kouzarides","year":"2007","unstructured":"Kouzarides T. Chromatin modifications and their function. Cell. 2007;128:693\u2013705. https:\/\/doi.org\/10.1016\/j.cell.2007.02.005.","journal-title":"Cell"},{"key":"1499_CR151","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1039\/c9np00057g","volume":"37","author":"LW Evans","year":"2020","unstructured":"Evans LW, Stratton MS, Ferguson BS. Dietary natural products as epigenetic modifiers in aging-associated inflammation and disease. Nat Prod Rep. 2020;37:653\u201376. https:\/\/doi.org\/10.1039\/c9np00057g.","journal-title":"Nat Prod Rep"},{"key":"1499_CR152","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1016\/j.cell.2024.02.005","volume":"187","author":"Y Wu","year":"2024","unstructured":"Wu Y, Ma J, Yang X, Nan F, Zhang T, Ji S, et al. Neutrophil profiling illuminates anti-tumor antigen-presenting potency. Cell. 2024;187:1422\u2013.e24. https:\/\/doi.org\/10.1016\/j.cell.2024.02.005.","journal-title":"Cell"},{"key":"1499_CR153","doi-asserted-by":"publisher","first-page":"1982","DOI":"10.1161\/circulationaha.123.065506","volume":"149","author":"S Zhang","year":"2024","unstructured":"Zhang S, Zhang Y, Duan X, Wang B, Zhan Z. Targeting NPM1 epigenetically promotes postinfarction cardiac repair by reprogramming reparative macrophage metabolism. Circulation. 2024;149:1982\u20132001. https:\/\/doi.org\/10.1161\/circulationaha.123.065506.","journal-title":"Circulation"},{"key":"1499_CR154","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1038\/s41392-023-01333-7","volume":"8","author":"YL Wu","year":"2023","unstructured":"Wu YL, Lin ZJ, Li CC, Lin X, Shan SK, Guo B, et al. Epigenetic regulation in metabolic diseases: mechanisms and advances in clinical study. Signal Transduct Target Ther. 2023;8:98. https:\/\/doi.org\/10.1038\/s41392-023-01333-7.","journal-title":"Signal Transduct Target Ther"},{"key":"1499_CR155","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1038\/s41583-021-00540-x","volume":"23","author":"G Sanacora","year":"2022","unstructured":"Sanacora G, Yan Z, Popoli M. The stressed synapse 2.0: pathophysiological mechanisms in stress-related neuropsychiatric disorders. Nat Rev Neurosci. 2022;23:86\u2013103. https:\/\/doi.org\/10.1038\/s41583-021-00540-x.","journal-title":"Nat Rev Neurosci"},{"key":"1499_CR156","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.bbi.2022.02.025","volume":"102","author":"M Mazzocchi","year":"2022","unstructured":"Mazzocchi M, Goulding SR, Morales-Prieto N, Foley T, Collins LM, Sullivan AM, et al. Peripheral administration of the Class-IIa HDAC inhibitor MC1568 partially protects against nigrostriatal neurodegeneration in the striatal 6-OHDA rat model of Parkinson\u2019s disease. Brain Behav Immun. 2022;102:151\u201360. https:\/\/doi.org\/10.1016\/j.bbi.2022.02.025.","journal-title":"Brain Behav Immun"},{"key":"1499_CR157","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1038\/ng.3550","volume":"48","author":"MM Pradeepa","year":"2016","unstructured":"Pradeepa MM, Grimes GR, Kumar Y, Olley G, Taylor GC, Schneider R, et al. Histone H3 globular domain acetylation identifies a new class of enhancers. Nat Genet. 2016;48:681\u20136. https:\/\/doi.org\/10.1038\/ng.3550.","journal-title":"Nat Genet"},{"key":"1499_CR158","doi-asserted-by":"publisher","first-page":"5036","DOI":"10.1093\/nar\/gkf660","volume":"30","author":"R Pandey","year":"2002","unstructured":"Pandey R, M\u00fcller A, Napoli CA, Selinger DA, Pikaard CS, Richards EJ, Bender J, Mount DW, Jorgensen RA, et al. Analysis of histone acetyltransferase and histone deacetylase families of Arabidopsis thaliana suggests functional diversification of chromatin modification among multicellular eukaryotes. Nucleic Acids Res. 2002;30:5036\u201355. https:\/\/doi.org\/10.1093\/nar\/gkf660.","journal-title":"Nucleic Acids Res"},{"key":"1499_CR159","doi-asserted-by":"publisher","first-page":"158","DOI":"10.2174\/1570159x19666210609160017","volume":"20","author":"V Kumar","year":"2022","unstructured":"Kumar V, Kundu S, Singh A, Singh S. Understanding the role of histone deacetylase and their inhibitors in neurodegenerative disorders: current targets and future perspective. Curr Neuropharmacol. 2022;20:158\u201378. https:\/\/doi.org\/10.2174\/1570159x19666210609160017.","journal-title":"Curr Neuropharmacol"},{"key":"1499_CR160","doi-asserted-by":"publisher","first-page":"12708","DOI":"10.1021\/acsami.2c20990","volume":"15","author":"MN Sardoiwala","year":"2023","unstructured":"Sardoiwala MN, Sood A, Biswal L, Roy Choudhury S, Karmakar S. Reconstituted super paramagnetic protein \u201cmagnetotransferrin\u201d for brain targeting to attenuate Parkinsonism. ACS Appl Mater Interfaces. 2023;15:12708\u201318. https:\/\/doi.org\/10.1021\/acsami.2c20990.","journal-title":"ACS Appl Mater Interfaces"},{"key":"1499_CR161","doi-asserted-by":"publisher","DOI":"10.1111\/acel.13895","volume":"22","author":"D Marinho","year":"2023","unstructured":"Marinho D, Ferreira IL, Lorenzoni R, Cardoso SM, Santana I, Rego AC. Reduction of class I histone deacetylases ameliorates ER-mitochondria cross-talk in Alzheimer\u2019s disease. Aging Cell. 2023;22:e13895. https:\/\/doi.org\/10.1111\/acel.13895.","journal-title":"Aging Cell"},{"key":"1499_CR162","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.stem.2018.10.023","volume":"24","author":"C Lang","year":"2019","unstructured":"Lang C, Campbell KR, Ryan BJ, Carling P, Attar M, Vowles J, et al. Single-cell sequencing of iPSC-dopamine neurons reconstructs disease progression and identifies HDAC4 as a regulator of Parkinson cell phenotypes. Cell Stem Cell. 2019;24:93\u2013106.e6. https:\/\/doi.org\/10.1016\/j.stem.2018.10.023.","journal-title":"Cell Stem Cell"},{"key":"1499_CR163","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1038\/s41386-023-01775-1","volume":"49","author":"X Dai","year":"2024","unstructured":"Dai X, Lin A, Zhuang L, Zeng Q, Cai L, Wei Y, et al. Targeting SIK3 to modulate hippocampal synaptic plasticity and cognitive function by regulating the transcription of HDAC4 in a mouse model of Alzheimer\u2019s disease. Neuropsychopharmacology. 2024;49:942\u201352. https:\/\/doi.org\/10.1038\/s41386-023-01775-1.","journal-title":"Neuropsychopharmacology"},{"key":"1499_CR164","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202304545","volume":"11","author":"P Mondal","year":"2024","unstructured":"Mondal P, Bai P, Gomm A, Bakiasi G, Lin CJ, Wang Y, et al. Structure-based discovery of a small molecule inhibitor of histone deacetylase 6 (HDAC6) that significantly reduces Alzheimer\u2019s disease neuropathology. Adv Sci. 2024;11:e2304545. https:\/\/doi.org\/10.1002\/advs.202304545.","journal-title":"Adv Sci"},{"key":"1499_CR165","doi-asserted-by":"publisher","first-page":"24","DOI":"10.5483\/BMBRep.2019.52.1.290","volume":"52","author":"SH Lee","year":"2019","unstructured":"Lee SH, Lee JH, Lee HY, Min KJ. Sirtuin signaling in cellular senescence and aging. BMB Rep. 2019;52:24\u201334. https:\/\/doi.org\/10.5483\/BMBRep.2019.52.1.290.","journal-title":"BMB Rep"},{"key":"1499_CR166","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/4854732","volume":"2018","author":"Y Wang","year":"2018","unstructured":"Wang Y, Lv D, Liu W, Li S, Chen J, Shen Y, et al. Disruption of the circadian clock alters antioxidative defense via the SIRT1-BMAL1 Pathway in 6-OHDA-induced models of Parkinson\u2019s disease. Oxid Med Cell Longev. 2018;2018:4854732. https:\/\/doi.org\/10.1155\/2018\/4854732.","journal-title":"Oxid Med Cell Longev"},{"key":"1499_CR167","doi-asserted-by":"publisher","DOI":"10.1186\/s12868-017-0364-1","volume":"18","author":"P Singh","year":"2017","unstructured":"Singh P, Hanson PS, Morris CM. SIRT1 ameliorates oxidative stress induced neural cell death and is down-regulated in Parkinson\u2019s disease. BMC Neurosci. 2017;18:46. https:\/\/doi.org\/10.1186\/s12868-017-0364-1.","journal-title":"BMC Neurosci"},{"key":"1499_CR168","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.14336\/ad.2020.0216","volume":"11","author":"X Li","year":"2020","unstructured":"Li X, Feng Y, Wang XX, Truong D, Wu YC. The critical role of SIRT1 in Parkinson\u2019s disease: mechanism and therapeutic considerations. Aging Dis. 2020;11:1608\u201322. https:\/\/doi.org\/10.14336\/ad.2020.0216.","journal-title":"Aging Dis"},{"key":"1499_CR169","doi-asserted-by":"publisher","first-page":"103","DOI":"10.3389\/fnagi.2020.00103","volume":"12","author":"BD Arbo","year":"2020","unstructured":"Arbo BD, Andr\u00e9-Miral C, Nasre-Nasser RG, Schimith LE, Santos MG, Costa-Silva D, et al. Resveratrol derivatives as potential treatments for Alzheimer\u2019s and Parkinson\u2019s disease. Front Aging Neurosci. 2020;12:103. https:\/\/doi.org\/10.3389\/fnagi.2020.00103.","journal-title":"Front Aging Neurosci"},{"key":"1499_CR170","doi-asserted-by":"publisher","first-page":"3039","DOI":"10.1111\/bph.16400","volume":"181","author":"F Sun","year":"2024","unstructured":"Sun F, Wang J, Meng L, Zhou Z, Xu Y, Yang M, et al. AdipoRon promotes amyloid-\u03b2 clearance through enhancing autophagy via nuclear GAPDH-induced sirtuin 1 activation in Alzheimer\u2019s disease. Br J Pharmacol. 2024;181:3039\u201363. https:\/\/doi.org\/10.1111\/bph.16400.","journal-title":"Br J Pharmacol"},{"key":"1499_CR171","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2024.102545","volume":"102","author":"R Thapa","year":"2024","unstructured":"Thapa R, Moglad E, Afzal M, Gupta G, Bhat AA, Hassan Almalki W, et al. The role of sirtuin 1 in ageing and neurodegenerative disease: A molecular perspective. Ageing Res Rev. 2024;102:102545. https:\/\/doi.org\/10.1016\/j.arr.2024.102545.","journal-title":"Ageing Res Rev"},{"key":"1499_CR172","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.neulet.2016.05.060","volume":"627","author":"KG Gebremedhin","year":"2016","unstructured":"Gebremedhin KG, Rademacher DJ. Histone H3 acetylation in the postmortem Parkinson\u2019s disease primary motor cortex. Neurosci Lett. 2016;627:121\u20135. https:\/\/doi.org\/10.1016\/j.neulet.2016.05.060.","journal-title":"Neurosci Lett"},{"key":"1499_CR173","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s13024-021-00450-7","volume":"16","author":"L Toker","year":"2021","unstructured":"Toker L, Tran GT, Sundaresan J, Tysnes OB, Alves G, Haugarvoll K, et al. Genome-wide histone acetylation analysis reveals altered transcriptional regulation in the Parkinson\u2019s disease brain. Mol Neurodegener. 2021;16:31. https:\/\/doi.org\/10.1186\/s13024-021-00450-7.","journal-title":"Mol Neurodegener"},{"key":"1499_CR174","doi-asserted-by":"publisher","unstructured":"Huang M, Lou D, Charli A, Kong D, Jin H, Zenitsky G, et al. Mitochondrial dysfunction-induced H3K27 hyperacetylation perturbs enhancers in Parkinson\u2019s disease. JCI Insight. 2021; 6:https:\/\/doi.org\/10.1172\/jci.insight.138088.","DOI":"10.1172\/jci.insight.138088"},{"key":"1499_CR175","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1385\/nmm:5:3:235","volume":"5","author":"G Gardian","year":"2004","unstructured":"Gardian G, Yang L, Cleren C, Calingasan NY, Klivenyi P, Beal MF. Neuroprotective effects of phenylbutyrate against MPTP neurotoxicity. Neuromolecular Med. 2004;5:235\u201341. https:\/\/doi.org\/10.1385\/nmm:5:3:235.","journal-title":"Neuromolecular Med"},{"key":"1499_CR176","doi-asserted-by":"publisher","first-page":"14941","DOI":"10.1074\/jbc.M110.211029","volume":"286","author":"W Zhou","year":"2011","unstructured":"Zhou W, Bercury K, Cummiskey J, Luong N, Lebin J, Freed CR. Phenylbutyrate up-regulates the DJ-1 protein and protects neurons in cell culture and in animal models of Parkinson disease. J Biol Chem. 2011;286:14941\u201351. https:\/\/doi.org\/10.1074\/jbc.M110.211029.","journal-title":"J Biol Chem"},{"key":"1499_CR177","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2022.101816","volume":"84","author":"A Kulkarni","year":"2023","unstructured":"Kulkarni A, Preeti K, Tryphena KP, Srivastava S, Singh SB, Khatri DK. Proteostasis in Parkinson\u2019s disease: Recent development and possible implication in diagnosis and therapeutics. Ageing Res Rev. 2023;84:101816. https:\/\/doi.org\/10.1016\/j.arr.2022.101816.","journal-title":"Ageing Res Rev"},{"key":"1499_CR178","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2023.176067","volume":"959","author":"ST Meka","year":"2023","unstructured":"Meka ST, Bojja SL, Kumar G, Birangal SR, Rao CM. Novel HDAC inhibitors provide neuroprotection in MPTP-induced Parkinson\u2019s disease model of rats. Eur J Pharmacol. 2023;959:176067. https:\/\/doi.org\/10.1016\/j.ejphar.2023.176067.","journal-title":"Eur J Pharmacol"},{"key":"1499_CR179","doi-asserted-by":"publisher","first-page":"16533","DOI":"10.1021\/acs.jmedchem.4c01367","volume":"67","author":"M Toledano-Pinedo","year":"2024","unstructured":"Toledano-Pinedo M, Porro-P\u00e9rez A, Sch\u00e4ker-H\u00fcbner L, Romero F, Dong M, Samadi A, et al. Contilisant+Tubastatin A Hybrids: polyfunctionalized indole derivatives as new HDAC inhibitor-based multitarget small molecules with in vitro and in vivo activity in neurodegenerative diseases. J Med Chem. 2024;67:16533\u201355. https:\/\/doi.org\/10.1021\/acs.jmedchem.4c01367.","journal-title":"J Med Chem"},{"key":"1499_CR180","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1073\/pnas.1013571108","volume":"108","author":"S Fnu","year":"2011","unstructured":"Fnu S, Williamson EA, De Haro LP, Brenneman M, Wray J, Shaheen M, et al. Methylation of histone H3 lysine 36 enhances DNA repair by nonhomologous end-joining. Proc Natl Acad Sci USA. 2011;108:540\u20135. https:\/\/doi.org\/10.1073\/pnas.1013571108.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1499_CR181","doi-asserted-by":"publisher","DOI":"10.1038\/srep36328","volume":"6","author":"N Sugeno","year":"2016","unstructured":"Sugeno N, J\u00e4ckel S, Voigt A, Wassouf Z, Schulze-Hentrich J, Kahle PJ. \u03b1-Synuclein enhances histone H3 lysine-9 dimethylation and H3K9me2-dependent transcriptional responses. Sci Rep. 2016;6:36328. https:\/\/doi.org\/10.1038\/srep36328.","journal-title":"Sci Rep"},{"key":"1499_CR182","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.202012188","volume":"13","author":"S Guhathakurta","year":"2021","unstructured":"Guhathakurta S, Kim J, Adams L, Basu S, Song MK, Adler E, et al. Targeted attenuation of elevated histone marks at SNCA alleviates \u03b1-synuclein in Parkinson\u2019s disease. EMBO Mol Med. 2021;13:e12188. https:\/\/doi.org\/10.15252\/emmm.202012188.","journal-title":"EMBO Mol Med"},{"key":"1499_CR183","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-020-03105-5","volume":"11","author":"MD Mu","year":"2020","unstructured":"Mu MD, Qian ZM, Yang SX, Rong KL, Yung WH, Ke Y. Therapeutic effect of a histone demethylase inhibitor in Parkinson\u2019s disease. Cell Death Dis. 2020;11:927. https:\/\/doi.org\/10.1038\/s41419-020-03105-5.","journal-title":"Cell Death Dis"},{"key":"1499_CR184","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1146\/annurev.biochem.67.1.425","volume":"67","author":"A Hershko","year":"1998","unstructured":"Hershko A, Ciechanover A. The ubiquitin system. Annu Rev Biochem. 1998;67:425\u201379. https:\/\/doi.org\/10.1146\/annurev.biochem.67.1.425.","journal-title":"Annu Rev Biochem"},{"key":"1499_CR185","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2020.108372","volume":"194","author":"AK Srivastava","year":"2021","unstructured":"Srivastava AK, Choudhury SR, Karmakar S. Neuronal Bmi-1 is critical for melatonin induced ubiquitination and proteasomal degradation of \u03b1-synuclein in experimental Parkinson\u2019s disease models. Neuropharmacology. 2021;194:108372. https:\/\/doi.org\/10.1016\/j.neuropharm.2020.108372.","journal-title":"Neuropharmacology"},{"key":"1499_CR186","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1126\/science.1140481","volume":"317","author":"J Kim","year":"2007","unstructured":"Kim J, Inoue K, Ishii J, Vanti WB, Voronov SV, Murchison E, et al. A MicroRNA feedback circuit in midbrain dopamine neurons. Science. 2007;317:1220\u20134. https:\/\/doi.org\/10.1126\/science.1140481.","journal-title":"Science"},{"key":"1499_CR187","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-94734-z","volume":"11","author":"Q Chen","year":"2021","unstructured":"Chen Q, Deng N, Lu K, Liao Q, Long X, Gou D, et al. Elevated plasma miR-133b and miR-221-3p as biomarkers for early Parkinson\u2019s disease. Sci Rep. 2021;11:15268. https:\/\/doi.org\/10.1038\/s41598-021-94734-z.","journal-title":"Sci Rep"},{"key":"1499_CR188","doi-asserted-by":"publisher","first-page":"12726","DOI":"10.1074\/jbc.M109.086827","volume":"285","author":"E Doxakis","year":"2010","unstructured":"Doxakis E. Post-transcriptional regulation of alpha-synuclein expression by mir-7 and mir-153. J Biol Chem. 2010;285:12726\u201334. https:\/\/doi.org\/10.1074\/jbc.M109.086827.","journal-title":"J Biol Chem"},{"key":"1499_CR189","doi-asserted-by":"publisher","first-page":"2383","DOI":"10.1523\/jneurosci.3900-15.2016","volume":"36","author":"AD Thome","year":"2016","unstructured":"Thome AD, Harms AS, Volpicelli-Daley LA, Standaert DG. microRNA-155 regulates alpha-synuclein-induced inflammatory responses in models of Parkinson disease. J Neurosci. 2016;36:2383\u201390. https:\/\/doi.org\/10.1523\/jneurosci.3900-15.2016.","journal-title":"J Neurosci"},{"key":"1499_CR190","doi-asserted-by":"publisher","first-page":"2404","DOI":"10.1016\/j.ymthe.2017.08.017","volume":"25","author":"KJ McMillan","year":"2017","unstructured":"McMillan KJ, Murray TK, Bengoa-Vergniory N, Cordero-Llana O, Cooper J, Buckley A, et al. Loss of microRNA-7 regulation leads to \u03b1-synuclein accumulation and dopaminergic neuronal loss in vivo. Mol Ther. 2017;25:2404\u201314. https:\/\/doi.org\/10.1016\/j.ymthe.2017.08.017.","journal-title":"Mol Ther"},{"key":"1499_CR191","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.febslet.2014.12.014","volume":"589","author":"S Kabaria","year":"2015","unstructured":"Kabaria S, Choi DC, Chaudhuri AD, Mouradian MM, Junn E. Inhibition of miR-34b and miR-34c enhances \u03b1-synuclein expression in Parkinson\u2019s disease. FEBS Lett. 2015;589:319\u201325. https:\/\/doi.org\/10.1016\/j.febslet.2014.12.014.","journal-title":"FEBS Lett"},{"key":"1499_CR192","doi-asserted-by":"publisher","unstructured":"Citterio LA, Mancuso R, Agostini S, Meloni M, Clerici M. Serum and exosomal miR-7-1-5p and miR-223-3p as possible biomarkers for Parkinson\u2019s disease. Biomolecules. 2023; 13:https:\/\/doi.org\/10.3390\/biom13050865.","DOI":"10.3390\/biom13050865"},{"key":"1499_CR193","doi-asserted-by":"publisher","first-page":"156","DOI":"10.3389\/fncel.2014.00156","volume":"8","author":"A Vallelunga","year":"2014","unstructured":"Vallelunga A, Ragusa M, Di Mauro S, Iannitti T, Pilleri M, Biundo R, et al. Identification of circulating microRNAs for the differential diagnosis of Parkinson\u2019s disease and Multiple System Atrophy. Front Cell Neurosci. 2014;8:156. https:\/\/doi.org\/10.3389\/fncel.2014.00156.","journal-title":"Front Cell Neurosci"},{"key":"1499_CR194","doi-asserted-by":"publisher","first-page":"232","DOI":"10.3389\/fnagi.2017.00232","volume":"9","author":"Y Chen","year":"2017","unstructured":"Chen Y, Gao C, Sun Q, Pan H, Huang P, Ding J, et al. MicroRNA-4639 Is a regulator of DJ-1 expression and a potential early diagnostic marker for Parkinson\u2019s disease. Front Aging Neurosci. 2017;9:232. https:\/\/doi.org\/10.3389\/fnagi.2017.00232.","journal-title":"Front Aging Neurosci"},{"key":"1499_CR195","doi-asserted-by":"publisher","DOI":"10.1111\/acel.13840","volume":"22","author":"L He","year":"2023","unstructured":"He L, Chen Y, Lin S, Shen R, Pan H, Zhou Y, et al. Regulation of Hsa-miR-4639-5p expression and its potential role in the pathogenesis of Parkinson\u2019s disease. Aging Cell. 2023;22:e13840. https:\/\/doi.org\/10.1111\/acel.13840.","journal-title":"Aging Cell"},{"key":"1499_CR196","doi-asserted-by":"publisher","first-page":"5649","DOI":"10.3390\/ijms20225649","volume":"20","author":"SY Goh","year":"2019","unstructured":"Goh SY, Chao YX, Dheen ST, Tan EK, Tay SS. Role of MicroRNAs in Parkinson\u2019s disease. Int J Mol Sci. 2019;20:5649. https:\/\/doi.org\/10.3390\/ijms20225649.","journal-title":"Int J Mol Sci"},{"key":"1499_CR197","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1002\/ana.25490","volume":"85","author":"J Schulz","year":"2019","unstructured":"Schulz J, Takousis P, Wohlers I, Itua IOG, Dobricic V, R\u00fccker G, et al. Meta-analyses identify differentially expressed microRNAs in Parkinson\u2019s disease. Ann Neurol. 2019;85:835\u201351. https:\/\/doi.org\/10.1002\/ana.25490.","journal-title":"Ann Neurol"},{"key":"1499_CR198","doi-asserted-by":"publisher","first-page":"218","DOI":"10.3389\/fnins.2019.00218","volume":"13","author":"Z Yang","year":"2019","unstructured":"Yang Z, Li T, Cui Y, Li S, Cheng C, Shen B, et al. Elevated Plasma microRNA-105-5p level in patients with idiopathic Parkinson\u2019s disease: a potential disease biomarker. Front Neurosci. 2019;13:218. https:\/\/doi.org\/10.3389\/fnins.2019.00218.","journal-title":"Front Neurosci"},{"key":"1499_CR199","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.1002\/mds.29515","volume":"38","author":"P Schlie\u00dfer","year":"2023","unstructured":"Schlie\u00dfer P, Struebing FL, Northoff BH, Kurz A, R\u00e9mi J, Holdt L, et al. Detection of a Parkinson\u2019s disease-specific MicroRNA signature in nasal and oral swabs. Mov Disord. 2023;38:1706\u201315. https:\/\/doi.org\/10.1002\/mds.29515.","journal-title":"Mov Disord"},{"key":"1499_CR200","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-023-02956-x","volume":"20","author":"T Li","year":"2023","unstructured":"Li T, Tan X, Tian L, Jia C, Cheng C, Chen X, et al. The role of Nurr1-miR-30e-5p-NLRP3 axis in inflammation-mediated neurodegeneration: insights from mouse models and patients\u2019 studies in Parkinson\u2019s disease. J Neuroinflammation. 2023;20:274. https:\/\/doi.org\/10.1186\/s12974-023-02956-x.","journal-title":"J Neuroinflammation"},{"key":"1499_CR201","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1002\/mdc3.12865","volume":"7","author":"L Pollini","year":"2020","unstructured":"Pollini L, Galosi S, Nardecchia F, Musacchia F, Castello R, Nigro V, et al. Parkinsonism, intellectual disability, and catatonia in a young male with MECP2 variant. Mov Disord Clin Pract. 2020;7:118\u20139. https:\/\/doi.org\/10.1002\/mdc3.12865.","journal-title":"Mov Disord Clin Pract"},{"key":"1499_CR202","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1038\/s41420-022-01063-9","volume":"8","author":"Q Cao","year":"2022","unstructured":"Cao Q, Zou Q, Zhao X, Zhang Y, Qu Y, Wang N, et al. Regulation of BDNF transcription by Nrf2 and MeCP2 ameliorates MPTP-induced neurotoxicity. Cell Death Discov. 2022;8:267. https:\/\/doi.org\/10.1038\/s41420-022-01063-9.","journal-title":"Cell Death Discov"},{"key":"1499_CR203","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.cell.2021.12.003","volume":"185","author":"CS Wang","year":"2022","unstructured":"Wang CS, Kavalali ET, Monteggia LM. BDNF signaling in context: From synaptic regulation to psychiatric disorders. Cell. 2022;185:62\u201376. https:\/\/doi.org\/10.1016\/j.cell.2021.12.003.","journal-title":"Cell"},{"key":"1499_CR204","doi-asserted-by":"publisher","first-page":"3067","DOI":"10.1093\/brain\/awaa262","volume":"143","author":"R Brauer","year":"2020","unstructured":"Brauer R, Wei L, Ma T, Athauda D, Girges C, Vijiaratnam N, et al. Diabetes medications and risk of Parkinson\u2019s disease: a cohort study of patients with diabetes. Brain. 2020;143:3067\u201376. https:\/\/doi.org\/10.1093\/brain\/awaa262.","journal-title":"Brain"},{"key":"1499_CR205","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-80723-1","volume":"11","author":"TY Jan","year":"2021","unstructured":"Jan TY, Wong LC, Yang MT, Huang CJ, Hsu CJ, Peng SS, et al. Correlation of dystonia severity and iron accumulation in Rett syndrome. Sci Rep. 2021;11:838. https:\/\/doi.org\/10.1038\/s41598-020-80723-1.","journal-title":"Sci Rep"},{"key":"1499_CR206","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1016\/j.freeradbiomed.2020.08.029","volume":"160","author":"X Zhang","year":"2020","unstructured":"Zhang X, Huang Z, Xie Z, Chen Y, Zheng Z, Wei X, et al. Homocysteine induces oxidative stress and ferroptosis of nucleus pulposus via enhancing methylation of GPX4. Free Radic Biol Med. 2020;160:552\u201365. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2020.08.029.","journal-title":"Free Radic Biol Med"},{"key":"1499_CR207","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1007\/s00415-022-11361-y","volume":"270","author":"MT Peri\u00f1\u00e1n","year":"2023","unstructured":"Peri\u00f1\u00e1n MT, Mac\u00edas-Garc\u00eda D, Jes\u00fas S, Mart\u00edn-Rodr\u00edguez JF, Mu\u00f1oz-Delgado L, Jimenez-Jaraba MV, et al. Homocysteine levels, genetic background, and cognitive impairment in Parkinson\u2019s disease. J Neurol. 2023;270:477\u201385. https:\/\/doi.org\/10.1007\/s00415-022-11361-y.","journal-title":"J Neurol"},{"key":"1499_CR208","doi-asserted-by":"publisher","first-page":"3187","DOI":"10.1007\/s12035-021-02320-1","volume":"58","author":"L Bai","year":"2021","unstructured":"Bai L, Yan F, Deng R, Gu R, Zhang X, Bai J. Thioredoxin-1 rescues MPP+\/MPTP-Induced ferroptosis by increasing glutathione peroxidase 4. Mol Neurobiol. 2021;58:3187\u201397. https:\/\/doi.org\/10.1007\/s12035-021-02320-1.","journal-title":"Mol Neurobiol"},{"key":"1499_CR209","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/5463134","volume":"2022","author":"Z Huang","year":"2022","unstructured":"Huang Z, Han J, Wu P, Wu C, Fan Y, Zhao L, et al. Sorting nexin 5 plays an important role in promoting ferroptosis in Parkinson\u2019s Disease. Oxid Med Cell Longev. 2022;2022:5463134. https:\/\/doi.org\/10.1155\/2022\/5463134.","journal-title":"Oxid Med Cell Longev"},{"key":"1499_CR210","doi-asserted-by":"publisher","first-page":"130","DOI":"10.3892\/mmr.2022.12645","volume":"25","author":"Q Shi","year":"2022","unstructured":"Shi Q, Liu R, Chen L. Ferroptosis inhibitor ferrostatin\u20111 alleviates homocysteine\u2011induced ovarian granulosa cell injury by regulating TET activity and DNA methylation. Mol Med Rep. 2022;25:130. https:\/\/doi.org\/10.3892\/mmr.2022.12645.","journal-title":"Mol Med Rep"},{"key":"1499_CR211","doi-asserted-by":"publisher","first-page":"32433","DOI":"10.1073\/pnas.2006828117","volume":"117","author":"JY Lee","year":"2020","unstructured":"Lee JY, Nam M, Son HY, Hyun K, Jang SY, Kim JW, et al. Polyunsaturated fatty acid biosynthesis pathway determines ferroptosis sensitivity in gastric cancer. Proc Natl Acad Sci USA. 2020;117:32433\u201342. https:\/\/doi.org\/10.1073\/pnas.2006828117.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1499_CR212","doi-asserted-by":"publisher","first-page":"4","DOI":"10.31083\/j.fbs1401004","volume":"14","author":"S Nakamura","year":"2022","unstructured":"Nakamura S. Integrated pathophysiology of schizophrenia, major depression, and bipolar disorder as monoamine axon disorder. Front Biosci 2022;14:4. https:\/\/doi.org\/10.31083\/j.fbs1401004.","journal-title":"Front Biosci"},{"key":"1499_CR213","doi-asserted-by":"publisher","unstructured":"Yamamoto H, Lee-Okada, Ikeda M, Nakamura T, Saito T, Takata A, et al. GWAS-identified bipolar disorder risk allele in the FADS1\/2 gene region links mood episodes and unsaturated fatty acid metabolism in mutant mice. Mol Psychiatry. 2023;. https:\/\/doi.org\/10.1038\/s41380-023-01988-2.","DOI":"10.1038\/s41380-023-01988-2"},{"key":"1499_CR214","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2022.102408","volume":"55","author":"LB Pontel","year":"2022","unstructured":"Pontel LB, Bueno-Costa A, Morellato AE, Carvalho Santos J, Rou\u00e9 G, Esteller M. Acute lymphoblastic leukemia necessitates GSH-dependent ferroptosis defenses to overcome FSP1-epigenetic silencing. Redox Biol. 2022;55:102408. https:\/\/doi.org\/10.1016\/j.redox.2022.102408.","journal-title":"Redox Biol"},{"key":"1499_CR215","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1002\/mds.27990","volume":"35","author":"L Chen","year":"2020","unstructured":"Chen L, Xie J. Ferroptosis-Suppressor-Protein 1: A potential neuroprotective target for combating ferroptosis. Mov Disord. 2020;35:400. https:\/\/doi.org\/10.1002\/mds.27990.","journal-title":"Mov Disord"},{"key":"1499_CR216","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-15065-7","volume":"11","author":"CL Vallerga","year":"2020","unstructured":"Vallerga CL, Zhang F, Fowdar J, McRae AF, Qi T, Nabais MF, et al. Analysis of DNA methylation associates the cystine-glutamate antiporter SLC7A11 with risk of Parkinson\u2019s disease. Nat Commun. 2020;11:1238. https:\/\/doi.org\/10.1038\/s41467-020-15065-7.","journal-title":"Nat Commun"},{"key":"1499_CR217","doi-asserted-by":"publisher","first-page":"2298","DOI":"10.3748\/wjg.v19.i15.2298","volume":"19","author":"M Itou","year":"2013","unstructured":"Itou M, Kawaguchi T, Taniguchi E, Sata M. Dipeptidyl peptidase-4: a key player in chronic liver disease. World J Gastroenterol. 2013;19:2298\u2013306. https:\/\/doi.org\/10.3748\/wjg.v19.i15.2298.","journal-title":"World J Gastroenterol"},{"key":"1499_CR218","doi-asserted-by":"publisher","first-page":"1692","DOI":"10.1016\/j.celrep.2017.07.055","volume":"20","author":"Y Xie","year":"2017","unstructured":"Xie Y, Zhu S, Song X, Sun X, Fan Y, Liu J, et al. The tumor suppressor p53 limits ferroptosis by blocking DPP4 activity. Cell Rep. 2017;20:1692\u2013704. https:\/\/doi.org\/10.1016\/j.celrep.2017.07.055.","journal-title":"Cell Rep"},{"key":"1499_CR219","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1038\/oby.2010.198","volume":"19","author":"V Turcot","year":"2011","unstructured":"Turcot V, Bouchard L, Faucher G, Tchernof A, Deshaies Y, P\u00e9russe L, et al. DPP4 gene DNA methylation in the omentum is associated with its gene expression and plasma lipid profile in severe obesity. Obesity. 2011;19:388\u201395. https:\/\/doi.org\/10.1038\/oby.2010.198.","journal-title":"Obesity"},{"key":"1499_CR220","doi-asserted-by":"publisher","first-page":"7343","DOI":"10.1007\/s12035-016-0197-4","volume":"54","author":"Z Wang","year":"2017","unstructured":"Wang Z, Zhang Y, Fang J, Yu F, Heng D, Fan Y, et al. Decreased methylation level of H3K27me3 increases seizure susceptibility. Mol Neurobiol. 2017;54:7343\u201352. https:\/\/doi.org\/10.1007\/s12035-016-0197-4.","journal-title":"Mol Neurobiol."},{"key":"1499_CR221","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1007\/s12072-022-10459-9","volume":"17","author":"X Cui","year":"2023","unstructured":"Cui X, Yun X, Sun M, Li R, Lyu X, Lao Y, et al. HMGCL-induced \u03b2-hydroxybutyrate production attenuates hepatocellular carcinoma via DPP4-mediated ferroptosis susceptibility. Hepatol Int. 2023;17:377\u201392. https:\/\/doi.org\/10.1007\/s12072-022-10459-9.","journal-title":"Hepatol Int"},{"key":"1499_CR222","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/303294","volume":"2015","author":"S Sharma","year":"2015","unstructured":"Sharma S, Taliyan R. Targeting histone deacetylases: a novel approach in Parkinson\u2019s disease. Park Dis. 2015;2015:303294. https:\/\/doi.org\/10.1155\/2015\/303294.","journal-title":"Park Dis"},{"key":"1499_CR223","doi-asserted-by":"publisher","unstructured":"Logie E, Van Puyvelde B, Cuypers B, Schepers A, Berghmans H, Verdonck J, et al. Ferroptosis induction in multiple myeloma cells triggers DNA methylation and histone modification changes associated with cellular senescence. Int J Mol Sci. 2021; 22:https:\/\/doi.org\/10.3390\/ijms222212234.","DOI":"10.3390\/ijms222212234"},{"key":"1499_CR224","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1007\/s12640-022-00538-y","volume":"40","author":"ZB Tong","year":"2022","unstructured":"Tong ZB, Kim H, El Touny L, Simeonov A, Gerhold D. LUHMES dopaminergic neurons are uniquely susceptible to ferroptosis. Neurotox Res. 2022;40:1526\u201336. https:\/\/doi.org\/10.1007\/s12640-022-00538-y.","journal-title":"Neurotox Res"},{"key":"1499_CR225","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-41317-3","volume":"14","author":"C Cousu","year":"2023","unstructured":"Cousu C, Mulot E, De Smet A, Formichetti S, Lecoeuche D, Ren J, et al. Germinal center output is sustained by HELLS-dependent DNA-methylation-maintenance in B cells. Nat Commun. 2023;14:5695. https:\/\/doi.org\/10.1038\/s41467-023-41317-3.","journal-title":"Nat Commun"},{"key":"1499_CR226","doi-asserted-by":"publisher","first-page":"3293","DOI":"10.7150\/thno.19988","volume":"7","author":"Y Jiang","year":"2017","unstructured":"Jiang Y, Mao C, Yang R, Yan B, Shi Y, Liu X, et al. EGLN1\/c-Myc induced lymphoid-specific helicase inhibits ferroptosis through lipid metabolic gene expression changes. Theranostics. 2017;7:3293\u2013305. https:\/\/doi.org\/10.7150\/thno.19988.","journal-title":"Theranostics"},{"key":"1499_CR227","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2023.1231707","volume":"14","author":"P Wang","year":"2023","unstructured":"Wang P, Chen Q, Tang Z, Wang L, Gong B, Li M, et al. Uncovering ferroptosis in Parkinson\u2019s disease via bioinformatics and machine learning, and reversed deducing potential therapeutic natural products. Front Genet. 2023;14:1231707. https:\/\/doi.org\/10.3389\/fgene.2023.1231707.","journal-title":"Front Genet"},{"key":"1499_CR228","doi-asserted-by":"publisher","first-page":"e1005970","DOI":"10.1371\/journal.pgen.1005970","volume":"12","author":"J Kim","year":"2016","unstructured":"Kim J, Zhao H, Dan J, Kim S, Hardikar S, Hollowell D, et al. Maternal Setdb1 Is required for meiotic progression and preimplantation development in mouse. PLoS Genet. 2016;12:e1005970. https:\/\/doi.org\/10.1371\/journal.pgen.1005970.","journal-title":"PLoS Genet"},{"key":"1499_CR229","doi-asserted-by":"publisher","DOI":"10.1016\/j.abb.2021.109087","volume":"715","author":"T Liu","year":"2022","unstructured":"Liu T, Xu P, Ke S, Dong H, Zhan M, Hu Q, et al. Histone methyltransferase SETDB1 inhibits TGF-\u03b2-induced epithelial-mesenchymal transition in pulmonary fibrosis by regulating SNAI1 expression and the ferroptosis signaling pathway. Arch Biochem Biophys. 2022;715:109087. https:\/\/doi.org\/10.1016\/j.abb.2021.109087.","journal-title":"Arch Biochem Biophys"},{"key":"1499_CR230","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s12860-019-0243-y","volume":"20","author":"M Al Chiblak","year":"2019","unstructured":"Al Chiblak M, Steinbeck F, Thiesen HJ, Lorenz P. DUF3669, a \u201cdomain of unknown function\u201d within ZNF746 and ZNF777, oligomerizes and contributes to transcriptional repression. BMC Mol Cell Biol. 2019;20:60. https:\/\/doi.org\/10.1186\/s12860-019-0243-y.","journal-title":"BMC Mol Cell Biol"},{"key":"1499_CR231","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/j.cell.2011.02.010","volume":"144","author":"JH Shin","year":"2011","unstructured":"Shin JH, Ko HS, Kang H, Lee Y, Lee YI, Pletinkova O, et al. PARIS (ZNF746) repression of PGC-1\u03b1 contributes to neurodegeneration in Parkinson\u2019s disease. Cell. 2011;144:689\u2013702. https:\/\/doi.org\/10.1016\/j.cell.2011.02.010.","journal-title":"Cell"},{"key":"1499_CR232","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/nrc3409","volume":"13","author":"Y Yang","year":"2013","unstructured":"Yang Y, Bedford MT. Protein arginine methyltransferases and cancer. Nat Rev Cancer. 2013;13:37\u201350. https:\/\/doi.org\/10.1038\/nrc3409.","journal-title":"Nat Rev Cancer"},{"key":"1499_CR233","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1002\/mc.23550","volume":"62","author":"L Zhou","year":"2023","unstructured":"Zhou L, Jia X, Shang Y, Sun Y, Liu Z, Liu J, et al. PRMT1 inhibition promotes ferroptosis sensitivity via ACSL1 upregulation in acute myeloid leukemia. Mol Carcinog. 2023;62:1119\u201335. https:\/\/doi.org\/10.1002\/mc.23550.","journal-title":"Mol Carcinog"},{"key":"1499_CR234","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.bbrc.2020.05.016","volume":"530","author":"JH Nho","year":"2020","unstructured":"Nho JH, Park MJ, Park HJ, Lee JH, Choi JH, Oh SJ, et al. Protein arginine methyltransferase-1 stimulates dopaminergic neuronal cell death in a Parkinson\u2019s disease model. Biochem Biophys Res Commun. 2020;530:389\u201395. https:\/\/doi.org\/10.1016\/j.bbrc.2020.05.016.","journal-title":"Biochem Biophys Res Commun"},{"key":"1499_CR235","doi-asserted-by":"publisher","first-page":"537","DOI":"10.3389\/fphar.2020.00537","volume":"11","author":"S Shukla","year":"2020","unstructured":"Shukla S, Tekwani BL. Histone deacetylases inhibitors in neurodegenerative diseases, neuroprotection and neuronal differentiation. Front Pharmacol. 2020;11:537. https:\/\/doi.org\/10.3389\/fphar.2020.00537.","journal-title":"Front Pharmacol"},{"key":"1499_CR236","doi-asserted-by":"publisher","DOI":"10.1515\/tnsci-2022-0286","volume":"14","author":"M Zhang","year":"2023","unstructured":"Zhang M, Wang J, Li J, Kong F, Lin S. miR-101-3p improves neuronal morphology and attenuates neuronal apoptosis in ischemic stroke in young mice by downregulating HDAC9. Transl Neurosci. 2023;14:20220286. https:\/\/doi.org\/10.1515\/tnsci-2022-0286.","journal-title":"Transl Neurosci"},{"key":"1499_CR237","doi-asserted-by":"publisher","first-page":"2695","DOI":"10.7150\/ijbs.80735","volume":"19","author":"L Sanguigno","year":"2023","unstructured":"Sanguigno L, Guida N, Anzilotti S, Cuomo O, Mascolo L, Serani A, et al. Stroke by inducing HDAC9-dependent deacetylation of HIF-1 and Sp1, promotes TfR1 transcription and GPX4 reduction, thus determining ferroptotic neuronal death. Int J Biol Sci. 2023;19:2695\u2013710. https:\/\/doi.org\/10.7150\/ijbs.80735.","journal-title":"Int J Biol Sci"},{"key":"1499_CR238","doi-asserted-by":"publisher","first-page":"191","DOI":"10.3389\/fcell.2019.00191","volume":"7","author":"M Mazzocchi","year":"2019","unstructured":"Mazzocchi M, Wyatt SL, Mercatelli D, Morari M, Morales-Prieto N, Collins LM, et al. Gene co-expression analysis identifies histone deacetylase 5 and 9 expression in midbrain dopamine neurons and as regulators of neurite growth via bone morphogenetic protein signaling. Front Cell Dev Biol. 2019;7:191. https:\/\/doi.org\/10.3389\/fcell.2019.00191.","journal-title":"Front Cell Dev Biol"},{"key":"1499_CR239","doi-asserted-by":"publisher","first-page":"2687","DOI":"10.2174\/0929867324666170417100318","volume":"24","author":"D Pastore","year":"2017","unstructured":"Pastore D, Pacifici F, Capuani B, Palmirotta R, Dong C, Coppola A, et al. Sex-genetic interaction in the risk for cerebrovascular disease. Curr Med Chem. 2017;24:2687\u201399. https:\/\/doi.org\/10.2174\/0929867324666170417100318.","journal-title":"Curr Med Chem"},{"key":"1499_CR240","doi-asserted-by":"publisher","unstructured":"Bazan N, Bhattacharjee S, Kala-Bhattacharjee S, Ledet A, Mukherjee P. Elovanoids are neural resiliency epigenomic regulators targeting histone modifications, DNA methylation, tau phosphorylation, telomere integrity, senescence programming, and dendrite integrity. Res Sq. 2023;. https:\/\/doi.org\/10.21203\/rs.3.rs-3185942\/v1.","DOI":"10.21203\/rs.3.rs-3185942\/v1"},{"key":"1499_CR241","doi-asserted-by":"publisher","first-page":"43807","DOI":"10.1074\/jbc.M305841200","volume":"278","author":"VL Marcheselli","year":"2003","unstructured":"Marcheselli VL, Hong S, Lukiw WJ, Tian XH, Gronert K, Musto A, et al. Novel docosanoids inhibit brain ischemia-reperfusion-mediated leukocyte infiltration and pro-inflammatory gene expression. J Biol Chem. 2003;278:43807\u201317. https:\/\/doi.org\/10.1074\/jbc.M305841200.","journal-title":"J Biol Chem"},{"key":"1499_CR242","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.mam.2018.09.003","volume":"64","author":"NG Bazan","year":"2018","unstructured":"Bazan NG. Docosanoids and elovanoids from omega-3 fatty acids are pro-homeostatic modulators of inflammatory responses, cell damage and neuroprotection. Mol Aspects Med. 2018;64:18\u201333. https:\/\/doi.org\/10.1016\/j.mam.2018.09.003.","journal-title":"Mol Aspects Med"},{"key":"1499_CR243","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1007\/s10571-015-0206-6","volume":"35","author":"JM Calandria","year":"2015","unstructured":"Calandria JM, Sharp MW, Bazan NG. The docosanoid neuroprotectin D1 Induces TH-positive neuronal survival in a cellular model of Parkinson\u2019s disease. Cell Mol Neurobiol. 2015;35:1127\u201336. https:\/\/doi.org\/10.1007\/s10571-015-0206-6.","journal-title":"Cell Mol Neurobiol"},{"key":"1499_CR244","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1177\/1947601911410223","volume":"2","author":"Z Feng","year":"2011","unstructured":"Feng Z, Lin M, Wu R. The regulation of aging and longevity: a new and complex role of p53. Genes Cancer. 2011;2:443\u201352. https:\/\/doi.org\/10.1177\/1947601911410223.","journal-title":"Genes Cancer"},{"key":"1499_CR245","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1038\/nrc2723","volume":"9","author":"AJ Levine","year":"2009","unstructured":"Levine AJ, Oren M. The first 30 years of p53: growing ever more complex. Nat Rev Cancer. 2009;9:749\u201358. https:\/\/doi.org\/10.1038\/nrc2723.","journal-title":"Nat Rev Cancer"},{"key":"1499_CR246","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1038\/s41588-023-01480-1","volume":"55","author":"A Rodriguez-Meira","year":"2023","unstructured":"Rodriguez-Meira A, Norfo R, Wen S, Ch\u00e9deville AL, Rahman H, O\u2019Sullivan J, et al. Single-cell multi-omics identifies chronic inflammation as a driver of TP53-mutant leukemic evolution. Nat Genet. 2023;55:1531\u201341. https:\/\/doi.org\/10.1038\/s41588-023-01480-1.","journal-title":"Nat Genet"},{"key":"1499_CR247","doi-asserted-by":"publisher","first-page":"34655","DOI":"10.1074\/jbc.C200433200","volume":"277","author":"HH Ng","year":"2002","unstructured":"Ng HH, Xu RM, Zhang Y, Struhl K. Ubiquitination of histone H2B by Rad6 is required for efficient Dot1-mediated methylation of histone H3 lysine 79. J Biol Chem. 2002;277:34655\u20137. https:\/\/doi.org\/10.1074\/jbc.C200433200.","journal-title":"J Biol Chem"},{"key":"1499_CR248","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1038\/nature00883","volume":"418","author":"ZW Sun","year":"2002","unstructured":"Sun ZW, Allis CD. Ubiquitination of histone H2B regulates H3 methylation and gene silencing in yeast. Nature. 2002;418:104\u20138. https:\/\/doi.org\/10.1038\/nature00883.","journal-title":"Nature"},{"key":"1499_CR249","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1007\/s00018-020-03552-5","volume":"78","author":"AJ Cole","year":"2021","unstructured":"Cole AJ, Dickson KA, Liddle C, Stirzaker C, Shah JS, Clifton-Bligh R, et al. Ubiquitin chromatin remodelling after DNA damage is associated with the expression of key cancer genes and pathways. Cell Mol Life Sci. 2021;78:1011\u201327. https:\/\/doi.org\/10.1007\/s00018-020-03552-5.","journal-title":"Cell Mol Life Sci"},{"key":"1499_CR250","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.celrep.2016.09.022","volume":"17","author":"S-J Wang","year":"2016","unstructured":"Wang S-J, Li D, Ou Y, Jiang L, Chen Y, Zhao Y, et al. Acetylation is crucial for p53-mediated ferroptosis and tumor suppression. Cell Rep. 2016;17:366\u201373. https:\/\/doi.org\/10.1016\/j.celrep.2016.09.022.","journal-title":"Cell Rep"},{"key":"1499_CR251","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-022-04971-x","volume":"13","author":"Y Yang","year":"2022","unstructured":"Yang Y, Ma Y, Li Q, Ling Y, Zhou Y, Chu K, et al. STAT6 inhibits ferroptosis and alleviates acute lung injury via regulating P53\/SLC7A11 pathway. Cell Death Dis. 2022;13:530. https:\/\/doi.org\/10.1038\/s41419-022-04971-x.","journal-title":"Cell Death Dis"},{"key":"1499_CR252","doi-asserted-by":"publisher","DOI":"10.1016\/j.tiv.2021.105146","volume":"73","author":"S Li","year":"2021","unstructured":"Li S, Wang M, Wang Y, Guo Y, Tao X, Wang X, et al. p53-mediated ferroptosis is required for 1-methyl-4-phenylpyridinium-induced senescence of PC12 cells. Toxicol Vitro. 2021;73:105146. https:\/\/doi.org\/10.1016\/j.tiv.2021.105146.","journal-title":"Toxicol Vitro"},{"key":"1499_CR253","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1016\/j.cell.2023.01.020","volume":"186","author":"J Zhao","year":"2023","unstructured":"Zhao J, Jia Y, Mahmut D, Deik AA, Jeanfavre S, Clish CB, et al. Human hematopoietic stem cell vulnerability to ferroptosis. Cell. 2023;186:732\u2013.e16. https:\/\/doi.org\/10.1016\/j.cell.2023.01.020.","journal-title":"Cell"},{"key":"1499_CR254","first-page":"319","volume":"41","author":"M Oki","year":"2007","unstructured":"Oki M, Aihara H, Ito T. Role of histone phosphorylation in chromatin dynamics and its implications in diseases. Subcell Biochem. 2007;41:319\u201336.","journal-title":"Subcell Biochem"},{"key":"1499_CR255","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-023-06154-8","volume":"14","author":"S Liu","year":"2023","unstructured":"Liu S, Yao S, Yang H, Liu S, Wang Y. Autophagy: regulator of cell death. Cell Death Dis. 2023;14:648. https:\/\/doi.org\/10.1038\/s41419-023-06154-8.","journal-title":"Cell Death Dis"},{"key":"1499_CR256","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1126\/science.290.5497.1717","volume":"290","author":"DJ Klionsky","year":"2000","unstructured":"Klionsky DJ, Emr SD. Autophagy as a regulated pathway of cellular degradation. Science. 2000;290:1717\u201321. https:\/\/doi.org\/10.1126\/science.290.5497.1717.","journal-title":"Science"},{"key":"1499_CR257","doi-asserted-by":"publisher","first-page":"e159941","DOI":"10.1172\/jci159941","volume":"133","author":"Y Dai","year":"2023","unstructured":"Dai Y, Zhu C, Xiao W, Huang K, Wang X, Shi C, et al. Mycobacterium tuberculosis hijacks host TRIM21- and NCOA4-dependent ferritinophagy to enhance intracellular growth. J Clin Invest. 2023;133:e159941. https:\/\/doi.org\/10.1172\/jci159941.","journal-title":"J Clin Invest"},{"key":"1499_CR258","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/6986445","volume":"2022","author":"W Chen","year":"2022","unstructured":"Chen W, Yang W, Zhang C, Liu T, Zhu J, Wang H, et al. Modulation of the p38 MAPK Pathway by anisomycin promotes ferroptosis of hepatocellular carcinoma through phosphorylation of H3S10. Oxid Med Cell Longev. 2022;2022:6986445. https:\/\/doi.org\/10.1155\/2022\/6986445.","journal-title":"Oxid Med Cell Longev"},{"key":"1499_CR259","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1080\/15548627.2016.1187366","volume":"12","author":"W Hou","year":"2016","unstructured":"Hou W, Xie Y, Song X, Sun X, Lotze MT, Zeh HJ, et al. Autophagy promotes ferroptosis by degradation of ferritin. Autophagy. 2016;12:1425. https:\/\/doi.org\/10.1080\/15548627.2016.1187366.","journal-title":"Autophagy"},{"key":"1499_CR260","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1038\/cr.2016.95","volume":"26","author":"M Gao","year":"2016","unstructured":"Gao M, Monian P, Pan Q, Zhang W, Xiang J, Jiang X. Ferroptosis is an autophagic cell death process. Cell Res. 2016;26:1021\u201332. https:\/\/doi.org\/10.1038\/cr.2016.95.","journal-title":"Cell Res"},{"issue":"3","key":"1499_CR261","doi-asserted-by":"publisher","DOI":"10.31083\/j.fbl2803042","volume":"28","author":"Y Jiang","year":"2023","unstructured":"Jiang Y, Xie G, Alimujiang A, Xie H, Yang W, Yin F. et al. Protective effects of quercetin against MPP+-induced dopaminergic neurons Injury via the Nrf2 signaling pathway. Front Biosci. 2023;28:42. https:\/\/doi.org\/10.31083\/j.fbl2803042.","journal-title":"Front Biosci"},{"key":"1499_CR262","doi-asserted-by":"publisher","first-page":"8019","DOI":"10.18632\/aging.205801","volume":"16","author":"L Li","year":"2024","unstructured":"Li L, Xie K, Xie H, Wang L, Li Z, Lu Q, et al. AURKB promotes colorectal cancer progression by triggering the phosphorylation of histone H3 at serine 10 to activate CCNE1 expression. Aging. 2024;16:8019\u201330. https:\/\/doi.org\/10.18632\/aging.205801.","journal-title":"Aging"},{"key":"1499_CR263","doi-asserted-by":"publisher","DOI":"10.1186\/s13148-020-00941-2","volume":"12","author":"D Komar","year":"2020","unstructured":"Komar D, Juszczynski P. Rebelled epigenome: histone H3S10 phosphorylation and H3S10 kinases in cancer biology and therapy. Clin Epigenetics. 2020;12:147. https:\/\/doi.org\/10.1186\/s13148-020-00941-2.","journal-title":"Clin Epigenetics"},{"key":"1499_CR264","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-13-124","volume":"13","author":"B Li","year":"2013","unstructured":"Li B, Huang G, Zhang X, Li R, Wang J, Dong Z, et al. Increased phosphorylation of histone H3 at serine 10 is involved in Epstein-Barr virus latent membrane protein-1-induced carcinogenesis of nasopharyngeal carcinoma. BMC Cancer. 2013;13:124. https:\/\/doi.org\/10.1186\/1471-2407-13-124.","journal-title":"BMC Cancer"},{"key":"1499_CR265","doi-asserted-by":"publisher","first-page":"12","DOI":"10.7150\/thno.8799","volume":"5","author":"R Pacaud","year":"2015","unstructured":"Pacaud R, Cheray M, Nadaradjane A, Vallette FM, Cartron PF. Histone H3 phosphorylation in GBM: a new rationale to guide the use of kinase inhibitors in anti-GBM therapy. Theranostics. 2015;5:12\u201322. https:\/\/doi.org\/10.7150\/thno.8799.","journal-title":"Theranostics"},{"key":"1499_CR266","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1126\/science.1152326","volume":"319","author":"EV Makeyev","year":"2008","unstructured":"Makeyev EV, Maniatis T. Multilevel regulation of gene expression by microRNAs. Science. 2008;319:1789\u201390. https:\/\/doi.org\/10.1126\/science.1152326.","journal-title":"Science"},{"key":"1499_CR267","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.cell.2009.01.002","volume":"136","author":"DP Bartel","year":"2009","unstructured":"Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell. 2009;136:215\u201333. https:\/\/doi.org\/10.1016\/j.cell.2009.01.002.","journal-title":"Cell"},{"key":"1499_CR268","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2019.104515","volume":"150","author":"E Angelopoulou","year":"2019","unstructured":"Angelopoulou E, Paudel YN, Piperi C. miR-124 and Parkinson\u2019s disease: A biomarker with therapeutic potential. Pharmacol Res. 2019;150:104515. https:\/\/doi.org\/10.1016\/j.phrs.2019.104515.","journal-title":"Pharmacol Res"},{"key":"1499_CR269","doi-asserted-by":"publisher","first-page":"3176","DOI":"10.1016\/j.ymthe.2022.06.003","volume":"30","author":"M Esteves","year":"2022","unstructured":"Esteves M, Abreu R, Fernandes H, Serra-Almeida C, Martins PAT, Bar\u00e3o M, et al. MicroRNA-124-3p-enriched small extracellular vesicles as a therapeutic approach for Parkinson\u2019s disease. Mol Ther. 2022;30:3176\u201392. https:\/\/doi.org\/10.1016\/j.ymthe.2022.06.003.","journal-title":"Mol Ther"},{"key":"1499_CR270","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-022-01407-8","volume":"20","author":"L Wu","year":"2022","unstructured":"Wu L, Tian X, Zuo H, Zheng W, Li X, Yuan M, et al. miR-124-3p delivered by exosomes from heme oxygenase-1 modified bone marrow mesenchymal stem cells inhibits ferroptosis to attenuate ischemia-reperfusion injury in steatotic grafts. J Nanobiotechnol. 2022;20:196. https:\/\/doi.org\/10.1186\/s12951-022-01407-8.","journal-title":"J Nanobiotechnol"},{"key":"1499_CR271","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-020-01665-2","volume":"20","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Li Y. Long non-coding RNA NORAD contributes to the proliferation, invasion and EMT progression of prostate cancer via the miR-30a-5p\/RAB11A\/WNT\/\u03b2-catenin pathway. Cancer Cell Int. 2020;20:571. https:\/\/doi.org\/10.1186\/s12935-020-01665-2.","journal-title":"Cancer Cell Int"},{"key":"1499_CR272","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2019.101402","volume":"29","author":"H Zhang","year":"2020","unstructured":"Zhang H, He Y, Wang JX, Chen MH, Xu JJ, Jiang MH, et al. miR-30-5p-mediated ferroptosis of trophoblasts is implicated in the pathogenesis of preeclampsia. Redox Biol. 2020;29:101402. https:\/\/doi.org\/10.1016\/j.redox.2019.101402.","journal-title":"Redox Biol"},{"key":"1499_CR273","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1007\/s11033-019-04614-z","volume":"46","author":"A Vallelunga","year":"2019","unstructured":"Vallelunga A, Iannitti T, Dati G, Capece S, Maugeri M, Tocci E, et al. Serum miR-30c-5p is a potential biomarker for multiple system atrophy. Mol Biol Rep. 2019;46:1661\u20136. https:\/\/doi.org\/10.1007\/s11033-019-04614-z.","journal-title":"Mol Biol Rep"},{"key":"1499_CR274","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/s12033-020-00283-7","volume":"63","author":"S Jayaprakash","year":"2021","unstructured":"Jayaprakash S, Le LTM, Sander B, Golas MM. Expression of the Neural REST\/NRSF-SIN3 Transcriptional Corepressor complex as a target for small-molecule inhibitors. Mol Biotechnol. 2021;63:53\u201362. https:\/\/doi.org\/10.1007\/s12033-020-00283-7.","journal-title":"Mol Biotechnol"},{"key":"1499_CR275","doi-asserted-by":"publisher","first-page":"5557","DOI":"10.1007\/s12035-023-03437-1","volume":"60","author":"A Nassar","year":"2023","unstructured":"Nassar A, Satarker S, Gurram PC, Upadhya D, Fayaz SM, Nampoothiri M. Repressor Element-1 Binding Transcription Factor (REST) as a possible epigenetic regulator of neurodegeneration and microRNA-based therapeutic strategies. Mol Neurobiol. 2023;60:5557\u201377. https:\/\/doi.org\/10.1007\/s12035-023-03437-1.","journal-title":"Mol Neurobiol"},{"key":"1499_CR276","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/7671324","volume":"2022","author":"J Ma","year":"2022","unstructured":"Ma J, Li X, Fan Y, Yang D, Gu Q, Li D, et al. miR-494-3p promotes erastin-induced ferroptosis by targeting REST to activate the Interplay between SP1 and ACSL4 in Parkinson\u2019s Disease. Oxid Med Cell Longev. 2022;2022:7671324. https:\/\/doi.org\/10.1155\/2022\/7671324.","journal-title":"Oxid Med Cell Longev"},{"key":"1499_CR277","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2021.700959","volume":"13","author":"L Li","year":"2021","unstructured":"Li L, Ren J, Pan C, Li Y, Xu J, Dong H, et al. Serum miR-214 serves as a biomarker for prodromal Parkinson\u2019s disease. Front Aging Neurosci. 2021;13:700959. https:\/\/doi.org\/10.3389\/fnagi.2021.700959.","journal-title":"Front Aging Neurosci"},{"key":"1499_CR278","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1038\/s41420-023-01608-6","volume":"9","author":"J Luo","year":"2023","unstructured":"Luo J, Song G, Chen N, Xie M, Niu X, Zhou S, et al. Ferroptosis contributes to ethanol-induced hepatic cell death via labile iron accumulation and GPx4 inactivation. Cell Death Discov. 2023;9:311. https:\/\/doi.org\/10.1038\/s41420-023-01608-6.","journal-title":"Cell Death Discov"},{"key":"1499_CR279","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.tins.2021.12.002","volume":"45","author":"EM Rocha","year":"2022","unstructured":"Rocha EM, Keeney MT, Di Maio R, De Miranda BR, Greenamyre JT. LRRK2 and idiopathic Parkinson\u2019s disease. Trends Neurosci. 2022;45:224\u201336. https:\/\/doi.org\/10.1016\/j.tins.2021.12.002.","journal-title":"Trends Neurosci"},{"key":"1499_CR280","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1146\/annurev-pathmechdis-031521-4145","volume":"18","author":"H Ye","year":"2023","unstructured":"Ye H, Robak LA, Yu M, Cykowski M, Shulman JM. Genetics and pathogenesis of Parkinson\u2019s syndrome. Annu Rev Pathol. 2023;18:95\u2013121. https:\/\/doi.org\/10.1146\/annurev-pathmechdis-031521-4145.","journal-title":"Annu Rev Pathol"},{"key":"1499_CR281","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/s1474-4422(23)00405-2","volume":"23","author":"T Simuni","year":"2024","unstructured":"Simuni T, Chahine LM, Poston K, Brumm M, Buracchio T, Campbell M, et al. A biological definition of neuronal \u03b1-synuclein disease: towards an integrated staging system for research. Lancet Neurol. 2024;23:178\u201390. https:\/\/doi.org\/10.1016\/s1474-4422(23)00405-2.","journal-title":"Lancet Neurol"},{"key":"1499_CR282","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/s1474-4422(21)00030-2","volume":"20","author":"E Tolosa","year":"2021","unstructured":"Tolosa E, Garrido A, Scholz SW, Poewe W. Challenges in the diagnosis of Parkinson\u2019s disease. Lancet Neurol. 2021;20:385\u201397. https:\/\/doi.org\/10.1016\/s1474-4422(21)00030-2.","journal-title":"Lancet Neurol"},{"key":"1499_CR283","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1148\/radiol.2021203341","volume":"300","author":"YJ Bae","year":"2021","unstructured":"Bae YJ, Kim JM, Sohn CH, Choi JH, Choi BS, Song YS, et al. Imaging the substantia nigra in Parkinson disease and other Parkinsonian syndromes. Radiology. 2021;300:260\u201378. https:\/\/doi.org\/10.1148\/radiol.2021203341.","journal-title":"Radiology"},{"key":"1499_CR284","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1056\/NEJMoa2312323","volume":"390","author":"WG Meissner","year":"2024","unstructured":"Meissner WG, Remy P, Giordana C, Malt\u00eate D, Derkinderen P, Hou\u00e9to JL, et al. Trial of lixisenatide in early Parkinson\u2019s disease. N Engl J Med. 2024;390:1176\u201385. https:\/\/doi.org\/10.1056\/NEJMoa2312323.","journal-title":"N Engl J Med"},{"key":"1499_CR285","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1038\/s41586-023-05795-1","volume":"616","author":"D Zhang","year":"2023","unstructured":"Zhang D, Deng Y, Kukanja P, Agirre E, Bartosovic M, Dong M, et al. Spatial epigenome-transcriptome co-profiling of mammalian tissues. Nature. 2023;616:113\u201322. https:\/\/doi.org\/10.1038\/s41586-023-05795-1.","journal-title":"Nature"},{"key":"1499_CR286","doi-asserted-by":"publisher","DOI":"10.1148\/rycan.220153","volume":"5","author":"E Mendes Serr\u00e3o","year":"2023","unstructured":"Mendes Serr\u00e3o E, Klug M, Moloney BM, Jhaveri A, Lo Gullo R, Pinker K, et al. Current status of cancer genomics and imaging phenotypes: what radiologists need to know. Radiol Imaging Cancer. 2023;5:e220153. https:\/\/doi.org\/10.1148\/rycan.220153.","journal-title":"Radiol Imaging Cancer"},{"key":"1499_CR287","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1002\/ana.26526","volume":"93","author":"T Schirinzi","year":"2023","unstructured":"Schirinzi T, Maftei D, Passali FM, Grillo P, Zenuni H, Mascioli D, et al. Olfactory neuron prokineticin-2 as a potential target in Parkinson\u2019s disease. Ann Neurol. 2023;93:196\u2013204. https:\/\/doi.org\/10.1002\/ana.26526.","journal-title":"Ann Neurol"},{"key":"1499_CR288","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1055\/s-0042-1755268","volume":"80","author":"S Trentin","year":"2022","unstructured":"Trentin S, Oliveira BSF, Borges YFF, Rieder CRM. Evaluation of the complete Sniffin Sticks Test versus its subtests in differentiating Parkinson\u2019s disease patients from healthy controls. Arq Neuropsiquiatr. 2022;80:908\u201313. https:\/\/doi.org\/10.1055\/s-0042-1755268.","journal-title":"Arq Neuropsiquiatr"},{"key":"1499_CR289","doi-asserted-by":"publisher","first-page":"13693","DOI":"10.1021\/acs.chemrev.3c00479","volume":"123","author":"DR Hill","year":"2023","unstructured":"Hill DR, Huters AD, Towne TB, Reddy RE, Fogle JL, Voight EA, et al. Parkinson\u2019s disease: advances in treatment and the syntheses of various classes of pharmaceutical drug substances. Chem Rev. 2023;123:13693\u2013712. https:\/\/doi.org\/10.1021\/acs.chemrev.3c00479.","journal-title":"Chem Rev"},{"key":"1499_CR290","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-04406-0","volume":"7","author":"J Li","year":"2017","unstructured":"Li J, Hao D, Wang L, Wang H, Wang Y, Zhao Z, et al. Epigenetic targeting drugs potentiate chemotherapeutic effects in solid tumor therapy. Sci Rep. 2017;7:4035. https:\/\/doi.org\/10.1038\/s41598-017-04406-0.","journal-title":"Sci Rep"},{"key":"1499_CR291","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/s41571-019-0267-4","volume":"17","author":"D Morel","year":"2020","unstructured":"Morel D, Jeffery D, Aspeslagh S, Almouzni G, Postel-Vinay S. Combining epigenetic drugs with other therapies for solid tumours - past lessons and future promise. Nat Rev Clin Oncol. 2020;17:91\u2013107. https:\/\/doi.org\/10.1038\/s41571-019-0267-4.","journal-title":"Nat Rev Clin Oncol"},{"key":"1499_CR292","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2023.102147","volume":"93","author":"J Burtscher","year":"2024","unstructured":"Burtscher J, Moraud EM, Malatesta D, Millet GP, Bally JF, Patoz A. Exercise and gait\/movement analyses in treatment and diagnosis of Parkinson\u2019s Disease. Ageing Res Rev. 2024;93:102147. https:\/\/doi.org\/10.1016\/j.arr.2023.102147.","journal-title":"Ageing Res Rev"},{"key":"1499_CR293","doi-asserted-by":"publisher","first-page":"Cd013856","DOI":"10.1002\/14651858.CD013856.pub2","volume":"1","author":"M Ernst","year":"2023","unstructured":"Ernst M, Folkerts AK, Gollan R, Lieker E, Caro-Valenzuela J, Adams A, et al. Physical exercise for people with Parkinson\u2019s disease: a systematic review and network meta-analysis. Cochrane Database Syst Rev. 2023;1:Cd013856. https:\/\/doi.org\/10.1002\/14651858.CD013856.pub2.","journal-title":"Cochrane Database Syst Rev"},{"key":"1499_CR294","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1038\/s41586-019-1678-1","volume":"574","author":"D Zhang","year":"2019","unstructured":"Zhang D, Tang Z, Huang H, Zhou G, Cui C, Weng Y, et al. Metabolic regulation of gene expression by histone lactylation. Nature. 2019;574:575\u201380. https:\/\/doi.org\/10.1038\/s41586-019-1678-1.","journal-title":"Nature"},{"key":"1499_CR295","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1016\/j.cmet.2022.02.013","volume":"34","author":"RY Pan","year":"2022","unstructured":"Pan RY, He L, Zhang J, Liu X, Liao Y, Gao J, et al. Positive feedback regulation of microglial glucose metabolism by histone H4 lysine 12 lactylation in Alzheimer\u2019s disease. Cell Metab. 2022;34:634\u2013.e6. https:\/\/doi.org\/10.1016\/j.cmet.2022.02.013.","journal-title":"Cell Metab"},{"key":"1499_CR296","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1016\/j.jcis.2024.03.001","volume":"663","author":"W Zou","year":"2024","unstructured":"Zou W, Gao F, Meng Z, Cai X, Chen W, Zheng Y, et al. Lactic acid responsive sequential production of hydrogen peroxide and consumption of glutathione for enhanced ferroptosis tumor therapy. J Colloid Interface Sci. 2024;663:787\u2013800. https:\/\/doi.org\/10.1016\/j.jcis.2024.03.001.","journal-title":"J Colloid Interface Sci"},{"key":"1499_CR297","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2021.105605","volume":"163","author":"J Li","year":"2022","unstructured":"Li J, Chen L, Qin Q, Wang D, Zhao J, Gao H, et al. Upregulated hexokinase 2 expression induces the apoptosis of dopaminergic neurons by promoting lactate production in Parkinson\u2019s disease. Neurobiol Dis. 2022;163:105605. https:\/\/doi.org\/10.1016\/j.nbd.2021.105605.","journal-title":"Neurobiol Dis"},{"key":"1499_CR298","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2023.176007","volume":"957","author":"Y Yu","year":"2023","unstructured":"Yu Y, Huang X, Liang C, Zhang P. Evodiamine impairs HIF1A histone lactylation to inhibit Sema3A-mediated angiogenesis and PD-L1 by inducing ferroptosis in prostate cancer. Eur J Pharmacol. 2023;957:176007. https:\/\/doi.org\/10.1016\/j.ejphar.2023.176007.","journal-title":"Eur J Pharmacol"},{"key":"1499_CR299","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1038\/s41580-019-0131-5","volume":"20","author":"A Pickar-Oliver","year":"2019","unstructured":"Pickar-Oliver A, Gersbach CA. The next generation of CRISPR-Cas technologies and applications. Nat Rev Mol Cell Biol. 2019;20:490\u2013507. https:\/\/doi.org\/10.1038\/s41580-019-0131-5.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1499_CR300","doi-asserted-by":"publisher","first-page":"2503","DOI":"10.1016\/j.cell.2021.03.025","volume":"184","author":"JK Nu\u00f1ez","year":"2021","unstructured":"Nu\u00f1ez JK, Chen J, Pommier GC, Cogan JZ, Replogle JM, Adriaens C, et al. Genome-wide programmable transcriptional memory by CRISPR-based epigenome editing. Cell. 2021;184:2503\u2013.e17. https:\/\/doi.org\/10.1016\/j.cell.2021.03.025.","journal-title":"Cell"}],"container-title":["Acta Pharmacologica Sinica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41401-025-01499-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41401-025-01499-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41401-025-01499-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T09:38:33Z","timestamp":1757151513000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41401-025-01499-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,11]]},"references-count":300,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["1499"],"URL":"https:\/\/doi.org\/10.1038\/s41401-025-01499-6","relation":{},"ISSN":["1671-4083","1745-7254"],"issn-type":[{"value":"1671-4083","type":"print"},{"value":"1745-7254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,11]]},"assertion":[{"value":"28 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}